<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3824101</article-id><article-id pub-id-type="doi">10.3389/fcimb.2013.00077</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Malireddi</surname><given-names>R. K. Subbarao</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kanneganti</surname><given-names>Thirumala-Devi</given-names></name><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref></contrib></contrib-group><aff><institution>Department of Immunology, St. Jude Children's Research Hospital</institution><country>Memphis, TN, USA</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Amal O. Amer, The Ohio State University, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Mikhail A. Gavrilin, The Ohio State University, USA; Dario S. Zamboni, Universidade de S&#x000e3;o Paulo, Brazil</p></fn><corresp id="fn001">*Correspondence: Thirumala-Devi Kanneganti, Department of Immunology, St. Jude Children's Research Hospital, MS #351, 262 Danny Thomas Place, Suite E7004, Memphis, TN 38105-2794, USA e-mail: <email xlink:type="simple">thirumala-devi.kanneganti@StJude.org</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to the journal Frontiers in Cellular and Infection Microbiology.</p></fn></author-notes><pub-date pub-type="epreprint"><day>17</day><month>9</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>12</day><month>11</month><year>2013</year></pub-date><pub-date pub-type="collection"><year>2013</year></pub-date><volume>3</volume><elocation-id>77</elocation-id><history><date date-type="received"><day>11</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Malireddi and Kanneganti.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Interferons (IFNs) were discovered over a half-century ago as antiviral factors. The role of type I IFNs has been studied in the pathogenesis of both acute and chronic microbial infections. Deregulated type I IFN production results in a damaging cascade of cell death, inflammation, and immunological host responses that can lead to tissue injury and disease progression. Here, we summarize the role of type I IFNs in the regulation of cell death and disease during different microbial infections, ranging from viruses and bacteria to fungal pathogens. Understanding the specific mechanisms driving type I IFN-mediated cell death and disease could aid in the development of targeted therapies.</p></abstract><kwd-group><kwd>type I IFN</kwd><kwd>IFN&#x003b2;</kwd><kwd>NLR</kwd><kwd>caspase-1</kwd><kwd>inflammasome</kwd><kwd>cell death</kwd><kwd>Nlrp3</kwd></kwd-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="152"/><page-count count="11"/><word-count count="10576"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Interferons (IFNs) are broadly classified into three groups, which are denoted as type I, II, and III based on the specific receptor utilization for their signal transduction. The type I IFN family comprises subtypes of IFN&#x003b1; (13 subtypes), IFN&#x003b2;, IFN&#x003c9;, and IFN&#x003b5; (Pestka et al., <xref ref-type="bibr" rid="B106">2004</xref>; Hertzog and Williams, <xref ref-type="bibr" rid="B52">2013</xref>). All of the type I IFNs bind to a common heterodimeric receptor, called the IFN&#x003b1;/&#x003b2; receptor (IFNAR), composed of two chains, IFNAR1 and IFNAR2, that are associated with the tyrosine kinases Tyk2 and Jak1. Activated Tyk2 and Jak1 recruit and phosphorylate several signal transducer and activator of transcription (STAT) family members (Figure <xref ref-type="fig" rid="F1">1</xref>) (Pestka et al., <xref ref-type="bibr" rid="B106">2004</xref>; Platanias, <xref ref-type="bibr" rid="B107">2005</xref>). Activated STAT1 forms a dimer with STAT2, leading to the recruitment of IRF9 and subsequent formation of a heterotrimeric complex called IFN-stimulated gene factor 3 (ISGF3) (Figure <xref ref-type="fig" rid="F1">1</xref>). This complex translocates to the nucleus, where it binds upstream IFN-stimulated response elements (ISRE) and activates the transcription of type I IFN-inducible genes (Pestka et al., <xref ref-type="bibr" rid="B106">2004</xref>; Platanias, <xref ref-type="bibr" rid="B107">2005</xref>). Type I IFNs are classically known for their antiviral immune responses; however, several studies have demonstrated that a wide range of non-viral pathogens can also induce their expression. However, the specific mechanisms and physiological consequences of IFN responses to such pathogens are poorly understood. Various studies have attributed contrasting roles and differential outcomes to type I IFNs in immune responses to diverse microbial pathogens. The ability of IFNs to regulate cell death has been known for a long time and recent studies have started to reveal the specific mechanisms involved.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Mechanisms involved in type I IFN production and its receptor signaling</bold>. Several different stimuli including pathogen derived LPS, glycoproteins, RNA and DNA can induce type I IFNs (IFN&#x003b1; and IFN&#x003b2;) via upstream pattern recognition receptors. TLRs sense the endosomally located PAMPs (pathogen associated molecular patterns) and DAMPs (damage associated molecular patterns) and recruit TRIF (TRL3 and TLR4) or Myd88 (TLR4, 7, 8, and 9), which further transfer the signals downstream to IRF3 and IRF7. RLRs, NLRs, DAI, STING, and related receptors sense nucleic acids in the cytoplasm. The RNA sensors, RIG-I, MDA-5, and LGP2, and DNA sensor STING use the adapter protein MAVS (mitochondrial antiviral signaling protein) to transfer signals to IRFs for type I IFN transcription. RIG-I and MDA-5 also sense ligands generated by RNA polymerase III from cytoplasmic DNA PAMPs. All these pathways utilize the common downstream kinases, TBK1/IKK&#x003b5; for activating Interferon transcription factors. Type I IFNs bind to IFNAR receptor and activate a robust transcriptional pathway through a JAK-STAT signaling pathway. The transcriptional complexes activated by type I IFN signaling bind to specific ISRE/GAS sequences and lead to the expression of several genes important for cell death, cell proliferation and immune responses.</p></caption><graphic xlink:href="fcimb-03-00077-g0001"/></fig><p>During the course of evolution, the arms race between bacterial pathogens and host organisms has resulted in the development of virulence mechanisms by microbes and the reciprocal development of host counter strategies to efficiently defend against them. Cell death has emerged as one of the important aspects of such a race between microbes and the host, exploited by both, while the final outcome is dependent on the specific pathogen and cell types involved. The in depth molecular mechanisms of how type I IFN signaling causes differential outcomes during different microbial infections remains to be established. Here we discuss the role of type I IFNs in regulating cell death and disease in various infection models and highlight its emerging role in inflammasome activation.</p></sec><sec><title>Intracellular bacteria</title><sec><title>listeria</title><p><italic>Listeria monocytogenes</italic> (LM), a gram-positive intracellular bacterium that grows rapidly inside host cells, is known to potently induce type I IFN production in mouse (Havell, <xref ref-type="bibr" rid="B49">1986</xref>; O'Riordan et al., <xref ref-type="bibr" rid="B100">2002</xref>) and human (Reimer et al., <xref ref-type="bibr" rid="B117">2007</xref>) macrophages. LM causes life-threatening infections in immunocompromised individuals and may lead to septic abortion in pregnant women (Pamer, <xref ref-type="bibr" rid="B102">2004</xref>). Upon internalization by phagocytes, LM escapes the early phagosome by secreting a hemolytic toxin, Listeriolysin O (LLO) (Portnoy et al., <xref ref-type="bibr" rid="B109">1988</xref>). <italic>Listeria</italic> mutants that do not express the LLO toxin fail to escape the phagosome or to induce IFN-&#x003b2; production. LM-induced type I IFN production is largely independent of TLR signaling and is instead mediated by cytoplasmic RLR- and STING-dependent pathways through the TBK1-IRF3 signaling axis (Ishikawa et al., <xref ref-type="bibr" rid="B56">2009</xref>; Woodward et al., <xref ref-type="bibr" rid="B146">2010</xref>). In addition, <italic>in vivo</italic> studies demonstrated that <italic>Irf</italic>3<sup>&#x02212;/&#x02212;</sup> and <italic>Ifnar</italic><sup>&#x02212;/&#x02212;</sup> mice, which neither make nor respond to type I IFNs, respectively, are highly resistant to <italic>L. monocytogenes</italic> infection (Auerbuch et al., <xref ref-type="bibr" rid="B5">2004</xref>; Carrero et al., <xref ref-type="bibr" rid="B20">2004</xref>; O'Connell et al., <xref ref-type="bibr" rid="B98">2004</xref>). Furthermore, priming with poly(I:C), a well known type I-inducing agent, results in enhanced death rate in LM-infected WT mice but not in <italic>Ifnar</italic><sup>&#x02212;/&#x02212;</sup> mice (O'Connell et al., <xref ref-type="bibr" rid="B98">2004</xref>), indicating a detrimental role for type I IFNs during <italic>Listeria</italic> infection. Moreover, LM-infected <italic>Ifnar</italic><sup>&#x02212;/&#x02212;</sup> mice were shown to have reduced lymphocyte and splenocyte apoptosis and antibody-dependent neutralization of LLO controlled infection that resulted in reduced pathology (Auerbuch et al., <xref ref-type="bibr" rid="B5">2004</xref>; Carrero et al., <xref ref-type="bibr" rid="B20">2004</xref>; O'Connell et al., <xref ref-type="bibr" rid="B98">2004</xref>). However, Rayamajhi et al. have proposed an alternative mechanism, where type I IFNs-dependent down-regulation of IFN&#x003b3; receptor results in heightened susceptibility of wild type mice to <italic>Listeria</italic> infection (Rayamajhi et al., <xref ref-type="bibr" rid="B115">2010</xref>).</p><p><italic>Listeria</italic> is known to trigger assembly of multiple types of inflammasomes that include Aim2, Nlrc4, and Nlrp3 for caspase-1 activation in mouse macrophages. During <italic>Listeria</italic> infection, type I IFNs have significant roles in regulation of inflammasome activation and pyroptosis (Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>; Kim et al., <xref ref-type="bibr" rid="B71">2010</xref>; Rathinam et al., <xref ref-type="bibr" rid="B113">2010</xref>; Wu et al., <xref ref-type="bibr" rid="B148">2010</xref>). A few studies have attempted to dissect the relative contributions of each of these inflammasomes and demonstrated that the detection of DNA by AIM2 receptor was indispensable for inflammasome activation and pyroptosis during <italic>Listeria</italic> infection in human PBMCs and mouse macrophages (Kim et al., <xref ref-type="bibr" rid="B71">2010</xref>; Rathinam et al., <xref ref-type="bibr" rid="B113">2010</xref>; Sauer et al., <xref ref-type="bibr" rid="B124">2010</xref>). In addition, Sauer et al. demonstrated that pyroptosis was totally dependent on Aim2, while the Nlrp3 and Nlrc4 inflammasomes were dispensable for this process (Sauer et al., <xref ref-type="bibr" rid="B124">2010</xref>). These reports implicate that type I IFNs play a role in the efficient induction of inflammasome activation and pyroptosis.</p></sec><sec><title>legionella</title><p><italic>Legionella pneumophila</italic> is an intracellular, gram-negative bacterial pathogen that replicates in host macrophages and causes a severe pneumonia called Legionnaires' disease. Lipmann et al. reported that <italic>L. pneumophila</italic>-infected mouse macrophages produce IFN&#x003b2; in a STING- and IRF3-dependent manner (Stetson and Medzhitov, <xref ref-type="bibr" rid="B129">2006a</xref>; Lippmann et al., <xref ref-type="bibr" rid="B77">2011</xref>). By contrast, Monroe et al. have demonstrated that <italic>L. pneumophila</italic> RNA also stimulated a Rig-I-dependent IFN response and proposed that <italic>L. pneumophila</italic> RNA, or host RNA, rather than <italic>L. pneumophila</italic> DNA, as the primary ligand that stimulates the host IFN response (Monroe et al., <xref ref-type="bibr" rid="B93">2009</xref>). IFN-&#x003b1;&#x003b2; inhibits <italic>L. pneumophila</italic> replication in the permissive A/J or CD1 mouse macrophages (Schiavoni et al., <xref ref-type="bibr" rid="B125">2004</xref>). Furthermore, Bastian et al. have reported that <italic>Legionella</italic> is controlled by IFN&#x003b2; induced in human lung epithelial cells via MAVS and IRF3 (Opitz et al., <xref ref-type="bibr" rid="B99">2006</xref>). Dendritic cells (DCs) and macrophages are capable of restricting <italic>L. pneumophila</italic> growth through NAIP5-dependent caspase-1 activation and cell death. However, DCs were shown to undergo a more rapid apoptosis than macrophages, leading to enhanced restriction of <italic>Legionella</italic> growth (Nogueira et al., <xref ref-type="bibr" rid="B96">2009</xref>). Indeed, eliminating the pro-apoptotic proteins BAX and BAK or over-expressing the anti-apoptotic protein BCL-2 were both found to restore <italic>L. pneumophila</italic> replication in DCs (Nogueira et al., <xref ref-type="bibr" rid="B96">2009</xref>). Furthermore, a sub-population of DCs, plasmacytoid DCs (pDCs) is known to express higher levels of IFNs (Liu, <xref ref-type="bibr" rid="B78">2005</xref>), which can potentially contribute to the higher cell death responses to <italic>Legionella</italic>. How <italic>Legionella</italic>-induced type I IFN promotes cell death is not well understood currently, however, one possible mechanism might be that Type I IFN-dependent up regulation of pro-cell death molecules like BAK and TRAIL can potentiate apoptosis (Fuertes Marraco et al., <xref ref-type="bibr" rid="B39">2011</xref>; Cohen and Prince, <xref ref-type="bibr" rid="B22">2013</xref>).</p></sec><sec><title>mycobacterium</title><p><italic>Mycobacterium</italic> spp. are pathogenic intracellular bacteria that cause tuberculosis (TB) and leprosy. Human and mouse myeloid cells secrete type I IFNs in response to mycobacterial infections (Pandey et al., <xref ref-type="bibr" rid="B103">2009</xref>; Berry et al., <xref ref-type="bibr" rid="B8">2010</xref>; Novikov et al., <xref ref-type="bibr" rid="B97">2011</xref>). Blood based profiling has identified type I IFN-induced genes as the most striking characteristic signature of active TB (Berry et al., <xref ref-type="bibr" rid="B8">2010</xref>). In addition, Wu et al. have reported that several TB-induced genes have key transcription factor binding sites for STATs, IRF-1, IRF-7, and OCT-1 (Wu et al., <xref ref-type="bibr" rid="B149">2012</xref>). IFN-&#x003b2; and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by <italic>M. leprae in vitro</italic> and were preferentially expressed in progressive lepromatous lesions (Teles et al., <xref ref-type="bibr" rid="B136">2013</xref>). Manca et al. have reported that type I IFNs enhance the virulence of <italic>M. tuberculosis</italic> by suppression of Th1 type immune responses. They have also shown that treatment with purified IFN-&#x003b1;/&#x003b2; increases lung bacterial loads, resulting in reduced survival in mice (Manca et al., <xref ref-type="bibr" rid="B83">2001</xref>). In addition, another study reported that treatment with exogenous type I IFN results in a striking loss of mycobacteriostatic activity in monocytes and macrophages (Bouchonnet et al., <xref ref-type="bibr" rid="B12">2002</xref>). Furthermore, Mayer-Barber et al. have shown that both IL-1&#x003b1; and IL-1&#x003b2; are critical for host resistance to TB and provided evidence that type I IFNs suppressed IL-1 production (Mayer-Barber et al., <xref ref-type="bibr" rid="B89">2011</xref>). However, early clinical studies suggested that type I IFNs have beneficial effects against pulmonary TB (Giosue et al., <xref ref-type="bibr" rid="B42">1998</xref>; Palmero et al., <xref ref-type="bibr" rid="B101">1999</xref>). Together, these studies indicate that the role of type I IFNs in mycobacterial infections is debatable and requires further research to establish a clear consensus.</p></sec><sec><title>francisella</title><p><italic>Francisella tularensis</italic> is a gram-negative bacterium and causes tularemia. <italic>F. tularensis</italic> is classified as a Class A agent (having a high potential for use as a bioweapon) by United States regulators, due to its high virulence and ability to spread rapidly. Cytosolic recognition of <italic>Francisella</italic> induces type I IFN production in an IRF3-dependent manner (Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>). <italic>Francisella</italic> induces Aim2 inflammasome-dependent pyroptosis, which further depends on the ability of the bacterium to induce type I IFN production (Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>; Fernandes-Alnemri et al., <xref ref-type="bibr" rid="B34">2010</xref>). Consistent with this, <italic>Francisella</italic>-induced Aim2 inflammasome activation and IL-1&#x003b2; secretion are abrogated in macrophages derived from bone marrow of <italic>Irf3</italic>- and <italic>Ifnar</italic>-deficient mice (Fernandes-Alnemri et al., <xref ref-type="bibr" rid="B34">2010</xref>; Jones et al., <xref ref-type="bibr" rid="B59">2010</xref>; Rathinam et al., <xref ref-type="bibr" rid="B113">2010</xref>). Wild-type <italic>Francisella</italic> that can escape into the cytosol induces type I IFN and Aim2 inflammasome activation and host cell death (Mariathasan et al., <xref ref-type="bibr" rid="B85">2005</xref>; Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>; Jones et al., <xref ref-type="bibr" rid="B59">2010</xref>). This observation underscores the importance of cytosolic recognition of bacteria or their components (DNA in the case of <italic>Francisella</italic>) as an important innate immune mechanism to trigger inflammasome activation. Although studies in mice certainly support an important role for Aim2 in immune responses to <italic>Francisella</italic>, its role in human monocytes seems to be less prominent due to its lack of expression and/or induction in response to type I IFNs (Gavrilin and Wewers, <xref ref-type="bibr" rid="B41">2011</xref>).</p></sec><sec><title>salmonella</title><p><italic>Salmonella enterica</italic> serovar Typhimurium (<italic>S. Typhimurium</italic>) is a gram-negative, intracellular pathogen that is quickly cleared by macrophages. This pathogen is a leading cause of acute gastroenteritis worldwide, which is transmitted primarily via the consumption of contaminated food or water. Induction of rapid cell death is a virulence strategy for this pathogen and contributes to dampening host innate immune responses (Lindgren et al., <xref ref-type="bibr" rid="B76">1996</xref>). Robinson et al. have reported that <italic>Salmonella</italic> exploits type I IFN signaling for eliminating macrophages to establish infection (Robinson et al., <xref ref-type="bibr" rid="B118">2012</xref>). Their studies also revealed that type I IFN-induced cell death of the macrophages is mediated by the classical RIP1-RIP3 dependent necroptosis pathway (Robinson et al., <xref ref-type="bibr" rid="B118">2012</xref>). <italic>Salmonella</italic> is detected by NLRP3 and NLRC4 inflammasomes resulting in casapse-1 activation and pyroptosis (Franchi et al., <xref ref-type="bibr" rid="B37">2006</xref>; Miao et al., <xref ref-type="bibr" rid="B90">2006</xref>; Broz et al., <xref ref-type="bibr" rid="B18">2010</xref>). Broz et al. have suggested the existence of an IFN-inducible regulator of caspase-11 that is crucial for activation of non-canonical Nlrp3 inflammasome activation in mutant <italic>Salmonella-</italic> [type 3 secretion system mutant, i.e., <italic>Salmonella</italic> pathogenicity island 1(SPI-1)] infected mouse macrophages (Broz et al., <xref ref-type="bibr" rid="B19">2012</xref>). Their study revealed that <italic>Salmonella</italic> induces expression and activation of caspase-11 through a Toll-like receptor 4 (TLR4)-dependent and TIR-domain containing adaptor-inducing IFN-&#x003b2; (TRIF)-mediated IFN&#x003b2; signaling pathway. Consistent with this, <italic>Ifnar1</italic><sup>&#x02212;/&#x02212;</sup> or <italic>Irf3</italic><sup>&#x02212;/&#x02212;</sup>, or <italic>Stat-1</italic><sup>&#x02212;/&#x02212;</sup> macrophages infected with mutant <italic>Salmonella</italic> did not process the casapase-11 or activate the non-canonical cell death pathway. Furthermore, <italic>in vivo Casp1</italic><sup>&#x02212;/&#x02212;</sup> mice are more susceptible to Salmonella infection than the <italic>Casp1</italic><sup>&#x02212;/&#x02212;</sup><italic>Casp11</italic><sup>&#x02212;/&#x02212;</sup> mice (Broz et al., <xref ref-type="bibr" rid="B19">2012</xref>). Thus, these results indicate that caspase-11 mediated cell death results in detrimental effects to the host. Together, it is evident that <italic>Salmonella</italic> exploits type I IFN signaling to rapidly kill the immune cells to cause disease in the host.</p></sec></sec><sec><title>Extracellular bacteria</title><sec><title>staphylococcus</title><p>Staphylococcal infections have recently emerged as a significant problem to human health, due to the emergence of antibiotic resistant strains that cause life-threatening infections, especially in post-influenza exposures (Klevens et al., <xref ref-type="bibr" rid="B72">2007</xref>; Martin et al., <xref ref-type="bibr" rid="B87">2009</xref>; David and Daum, <xref ref-type="bibr" rid="B24">2010</xref>). <italic>S. aureus</italic> infected mouse and human epithelial cells produce type I IFN in a STAT3-dependent manner in response to its virulent protein A (Martin et al., <xref ref-type="bibr" rid="B87">2009</xref>). In mouse myeloid DCs and macrophages, TLR9 and IRF1 have important roles (Schmitz et al., <xref ref-type="bibr" rid="B126">2007</xref>), while the cell wall component lipoteichoic acid (LTA) utilizes the IRF1-STAT1 axis in mouse macrophages to induce type I IFNs (Liljeroos et al., <xref ref-type="bibr" rid="B75">2008</xref>). Absence of IFNAR signaling results in protection against lethal <italic>S. aureus</italic> pneumonia infection compared to wild-type control mice (Martin et al., <xref ref-type="bibr" rid="B87">2009</xref>). Following recognition of <italic>S. aureus</italic> &#x003b1;-hemolysin, mouse macrophages undergo pyroptosis in an Nlrp3 inflammasome-dependent manner (Mariathasan et al., <xref ref-type="bibr" rid="B86">2006</xref>; Craven et al., <xref ref-type="bibr" rid="B23">2009</xref>). In contrast to Martin et al., a recent report demonstrated that IFN&#x003b1; induces phospholipid scramblase 1 (PLSCR1) in human lung epithelial cells as part of an innate protective mechanism to a bacterial pore-forming toxin (Lizak and Yarovinsky, <xref ref-type="bibr" rid="B79">2012</xref>) and another study demonstrated a protective role of CpG DNA (a potent inducer of type I IFN production) in a mouse model of <italic>S. aureus</italic> pneumonia (Roquilly et al., <xref ref-type="bibr" rid="B119">2010</xref>). Furthermore, Kaplan et al. have shown that phagosomal degradation and cytosolic release of intracellular ligands are essential for the induction of IFN-&#x003b2; in mouse and human DCs, which is required for the host defense against <italic>S. aureus</italic> during cutaneous infection in mice (Kaplan et al., <xref ref-type="bibr" rid="B65">2012</xref>). Taken together, these reports suggest that type I IFNs can have both protective and detrimental roles during <italic>S. aureus</italic> infection. The disease outcome is variable and may depend on the immune status of the host, the site of infection and the specific strains causing the infection.</p></sec><sec><title>streptococcus</title><p><italic>S. pneumonia</italic> causes acute lung infections and activates type I IFN expression (Joyce et al., <xref ref-type="bibr" rid="B60">2009</xref>; Parker et al., <xref ref-type="bibr" rid="B105">2011</xref>). DAI (DNA-dependent activator of IFN-regulatory factors) dependent recognition of bacterial DNA is proposed to be responsible for inducing type I IFN expression through cytoplasmic DNA sensing pathway involving STING, TBK1 and IRF3-dependent signaling pathways (Parker et al., <xref ref-type="bibr" rid="B105">2011</xref>). Type I IFN treatment enhances protection of mice against <italic>S. pneumoniae</italic> (Weigent et al., <xref ref-type="bibr" rid="B144">1986</xref>). However, prior exposure to influenza A virus leads to increased susceptibility to bacterial infections in a type I IFN-dependent manner (Morens et al., <xref ref-type="bibr" rid="B94">2008</xref>; Shahangian et al., <xref ref-type="bibr" rid="B127">2009</xref>). As opposed to bacterial infection alone, type I IFNs produced during secondary infection with <italic>S. pneumonia</italic> inhibits production of chemokines like CXCL1 and CXCL2 and sensitizes hosts to secondary bacterial pneumonia (Shahangian et al., <xref ref-type="bibr" rid="B127">2009</xref>).</p></sec><sec><title>pseudomonas</title><p><italic>Pseudomonas aeruginosa</italic> is a causative agent of pneumonia and infection in cystic fibrosis (CF) patients is associated with significant mortality (Zhuo et al., <xref ref-type="bibr" rid="B152">2008</xref>). <italic>P. aeruginosa</italic> induces type I IFN expression predominantly through the TLR4-TRIF-IRF3 axis (Parker et al., <xref ref-type="bibr" rid="B104">2012</xref>). TLR4 signaling was shown to be important for clearance of <italic>P. aeruginosa</italic> from the lungs and preventing sepsis in infected hosts (Faure et al., <xref ref-type="bibr" rid="B33">2004</xref>; Ramphal et al., <xref ref-type="bibr" rid="B112">2005</xref>; Skerrett et al., <xref ref-type="bibr" rid="B128">2007</xref>; Cohen and Prince, <xref ref-type="bibr" rid="B22">2013</xref>). Similarly, <italic>Trif</italic> and <italic>Irf</italic>3 deficiencies in mice resulted in reduced expression of type I IFN-induced chemokines including CXCL10 (IP-10) and CCL5 (RANTES) and abrogated neutrophil recruitment to the lungs leading to impaired bacterial clearance (Power et al., <xref ref-type="bibr" rid="B111">2007</xref>; Carrigan et al., <xref ref-type="bibr" rid="B21">2010</xref>). These results indicate a protective role for type I IFNs during <italic>P. aeruginosa</italic> infection (Roy et al., <xref ref-type="bibr" rid="B120">2013</xref>). <italic>P. aeruginosa</italic> infection of mouse macrophages activates the Nlrc4 inflammasome and induces pyroptosis in a flagellin independent manner (Sutterwala et al., <xref ref-type="bibr" rid="B131">2007</xref>). However, later studies demonstrated a requirement of cytosolic flagellin for Nlrc4 inflammasome activation (Miao et al., <xref ref-type="bibr" rid="B91">2008</xref>; Arlehamn and Evans, <xref ref-type="bibr" rid="B4">2011</xref>). Bacterial expression of specific adhesins, lipopolysaccharide, and a functional type III secretion system were all shown to be necessary to evoke apoptosis (Sutterwala et al., <xref ref-type="bibr" rid="B131">2007</xref>) and the cytotoxin, ExoU-expressing <italic>P. aeruginosa</italic> strain has been shown to inhibit caspase-1 dependent pyroptosis (Sutterwala et al., <xref ref-type="bibr" rid="B131">2007</xref>).</p></sec><sec><title>anthrax</title><p><italic>Bacillus anthracis</italic> is a gram-positive, aerobic bacterium that causes severe pulmonary, gastrointestinal, and cutaneous infections (Dixon et al., <xref ref-type="bibr" rid="B30">1999</xref>). Production of the lethal toxin (LeTx) by this bacterium causes extensive cell death, tissue damage and systemic disease. LeTx is composed of a protective antigen (PA) and lethal factor (LF). Gold et al. found that endogenous IFNs (type I and II) inhibit the germination of <italic>B. anthracis</italic> spores, but exogenous application enhanced inflammation thereby increasing mortality (Gold et al., <xref ref-type="bibr" rid="B43">2007</xref>). In addition, Walberg et al. showed that recombinant murine IFN&#x003b2; or type I IFN inducers like poly(I:C) provide marked protection against &#x0201c;Inhalation Anthrax&#x0201d; (Walberg et al., <xref ref-type="bibr" rid="B141">2008</xref>). <italic>B. anthracis</italic> LeTxs activate the Nlrp1b inflammasome and pyroptosis in mice (Boyden and Dietrich, <xref ref-type="bibr" rid="B15">2006</xref>; Bergsbaken et al., <xref ref-type="bibr" rid="B7">2009</xref>). It is recognized that macrophages from inbred mice may or may not be sensitive to <italic>B. anthracis-</italic>induced pyroptosis based on the presence of the Nlrp1b inflammasome responsive <italic>Nlrp1b<sup>S/S</sup></italic> or non-responsive <italic>Nlrp1b<sup>R/R</sup></italic> alleles (Moayeri et al., <xref ref-type="bibr" rid="B92">2010</xref>; Terra et al., <xref ref-type="bibr" rid="B137">2010</xref>). In this case, pyroptosis of macrophages is believed to counter anthrax infection since IL-1&#x003b2; released during this process helps to generate protective neutrophil responses. It will be essential to study the contribution of type I IFN in pyroptosis induction during <italic>B. anthracis</italic> infection and investigate whether type I IFN can promote apoptosis of neutrophils and initiate other possible detrimental effects.</p></sec></sec><sec><title>Viruses</title><p>IFNs were originally discovered as antiviral molecules. Viruses are considerably smaller than other microbial pathogens but represent a major threat to human and other animal health. Extensive progress has been made in understanding the mechanisms of type I IFN production in response to viruses (Stetson and Medzhitov, <xref ref-type="bibr" rid="B130">2006b</xref>; Gonzalez-Navajas et al., <xref ref-type="bibr" rid="B44">2012</xref>; MacMicking, <xref ref-type="bibr" rid="B81">2012</xref>). The diverse mechanisms of cellular entry and tropism of viruses are detected by different TLRs that are strategically located in different cellular compartments (Figure <xref ref-type="fig" rid="F1">1</xref>). Endosomally-located PRRs including TLR3, 7, 8, and 9 are known to trigger type I IFNs (Figure <xref ref-type="fig" rid="F1">1</xref>). TLR7 and TLR9 have particularly important roles in plasmacytoid DCs. Once the virus enters the host cytoplasm, several cytoplasmic receptors such as RIG-I-like receptors (RLRs RIG-I, MDA5 and LGP2) and NOD-like receptors (NOD1 and NOD2) monitor the cytoplasm for microbial PAMPs and initiate type I IFN production and associated immune responses (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><p>Programmed cell death is a critical host defense against viruses and type I IFNs are known to be involved to this process. Multiple viruses have been discovered to encode proteins that function to subvert host-induced cell death during infection (Bowie and Unterholzner, <xref ref-type="bibr" rid="B14">2008</xref>; Galluzzi et al., <xref ref-type="bibr" rid="B40">2010</xref>; Kaminskyy and Zhivotovsky, <xref ref-type="bibr" rid="B61">2010</xref>; Gregory et al., <xref ref-type="bibr" rid="B45">2011</xref>). Death of the infected cells is detrimental to viral replication and amplification of viral progeny. However, death of the infected cells can also facilitate viral egress and enhance pathogenesis. Therefore, different viruses have evolved complex mechanisms to enhance or inhibit different forms of cell death (Kaminskyy and Zhivotovsky, <xref ref-type="bibr" rid="B61">2010</xref>). Microarray based studies revealed that a large number of genes are regulated by type I IFNs and several of them are involved in cell death (Der et al., <xref ref-type="bibr" rid="B27">1998</xref>; de Veer et al., <xref ref-type="bibr" rid="B28">2001</xref>; Hertzog and Williams, <xref ref-type="bibr" rid="B52">2013</xref>; Rusinova et al., <xref ref-type="bibr" rid="B121">2013</xref>). However, the mechanisms driving cell death that involve proteins encoded by many of these genes are still awaited.</p><p>Uncontrolled chronic viral infections can result in sustained expression of type I IFNs with detrimental pathophysiological outcomes. Two recent studies reported the role of type I IFNs in viral persistence during lymphocytic choriomeningitis virus (LCMV) infection (Teijaro et al., <xref ref-type="bibr" rid="B135">2013</xref>; Wilson et al., <xref ref-type="bibr" rid="B145">2013</xref>). Results from these reports show that robust and acute type I IFNs secreted during early in the infection serve to control viral replication and spread by promoting apoptosis of infected cells and enhancing T cell activation. During chronic infection, prolonged expression and exposure to type I IFNs leads to lymphocyte exhaustion, and reduced viral clearance due to the presence of increased immunosuppressive molecules like IL-10 and PD-L1. Loss of circulating pDCs has been documented in chronic viral infections in mice and humans, which correlates with uncontrolled viral loads, reduced T cell counts and onset of opportunistic infections (Swiecki et al., <xref ref-type="bibr" rid="B133">2011</xref>). However, the mechanism of type I IFN-dependent pDC apoptosis is not entirely clear and represents an important subject for future research.</p><p>Type I IFNs promote cell death in multiple ways. Balachandran et al. have demonstrated that type I IFN and protein kinase R (PKR) can sensitize cells to apoptosis primarily through the FADD/caspase-8 pathway (Balachandran et al., <xref ref-type="bibr" rid="B6">2000</xref>). In this study, stimulation of mouse cells with IFN-&#x003b1;/&#x003b2; resulted in enhanced apoptosis and reduced viral replication. In a follow up study, Ezelle et al. showed that the poxvirus-encoded protein CrmA was able to inhibit both viral infection- and dsRNA-mediated apoptosis (Ezelle et al., <xref ref-type="bibr" rid="B32">2001</xref>). Both HSV and vaccinia virus affect PKR and RNase L-mediated apoptosis pathways that are activated by dsRNA products released during viral replication (Der et al., <xref ref-type="bibr" rid="B26">1997</xref>; Diaz-Guerra et al., <xref ref-type="bibr" rid="B29">1997</xref>; Kibler et al., <xref ref-type="bibr" rid="B70">1997</xref>). Influenza viruses cause severe lung pathology leading to lung failure and mortality. Type I IFNs have been recognized to mediate induction of pro-apoptotic TRAIL leading to excessive cell death and tissue injury (Hogner et al., <xref ref-type="bibr" rid="B53">2013</xref>). Infection or treatment with type I IFN induces pro-apoptotic genes; IFN-stimulated gene 54 (ISG54) or IFN-induced gene with tetratricopeptide repeats 2 (IFIT2) that promotes apoptosis by mitochondrial-associated BCL2 family proteins (Reich, <xref ref-type="bibr" rid="B116">2013</xref>).</p></sec><sec><title>Fungi</title><p>While type I IFNs are widely known as anti-viral factors, which are either protective or detrimental in bacterial infections, their role in fungal infections is poorly defined. Recently, two reports have shown that <italic>Candida</italic> spp. induce IFN-&#x003b2; in mouse bone marrow-derived DCs (BMDCs) and macrophages (Biondo et al., <xref ref-type="bibr" rid="B10">2008</xref>, <xref ref-type="bibr" rid="B9">2012</xref>; Bourgeois et al., <xref ref-type="bibr" rid="B13">2011</xref>). Different forms of fungal glucans and mannans are sensed by a wide range of innate pattern receptors like TLRs, CLRs, dectins, and mannose receptors and initiate MyD88&#x02013;mediated NF-&#x003ba;B and MAPK pathways or SYK-CARD9 signaling for cytokine induction and cell death (Netea et al., <xref ref-type="bibr" rid="B95">2008</xref>; Brown, <xref ref-type="bibr" rid="B16">2011</xref>). During fungal infections, type I IFNs are also produced by a TLR-independent pathway requiring RNA sensor MAVS and IRF3 (Inglis et al., <xref ref-type="bibr" rid="B55">2010</xref>). In contrast, Del Fresno et al. have recently reported that <italic>Candida albicans</italic> induces type I IFN in DCs through a DECTIN-1, SYK-, and CARD9-dependent pathway that requires IRF5-mediated transcription but not IRF3 or IRF7 (Del Fresno et al., <xref ref-type="bibr" rid="B25">2013</xref>). Jensen et al. have reported that poly(I:C)-induced or exogenously added IFN&#x003b1; and IFN&#x003b2; treatments of macrophages suppress anti-<italic>Candida</italic> immune responses and cause death of infected mice (Worthington and Hasenclever, <xref ref-type="bibr" rid="B147">1972</xref>; Jensen et al., <xref ref-type="bibr" rid="B58">1992</xref>; Jensen and Balish, <xref ref-type="bibr" rid="B57">1993</xref>). In addition, <italic>Ifnar</italic><sup>&#x02212;/&#x02212;</sup> mice are extremely resistant to otherwise lethal <italic>Candida</italic> and <italic>Histoplasma</italic> infections (Inglis et al., <xref ref-type="bibr" rid="B55">2010</xref>; Majer et al., <xref ref-type="bibr" rid="B82">2012</xref>). These studies demonstrated that type I IFNs induce severe kidney damage by promoting excessive recruitment and activation of inflammatory monocytes and neutrophils. However, other reports suggest that type I IFN can be beneficial as part of the host immune response to <italic>C. albicans</italic> (Biondo et al., <xref ref-type="bibr" rid="B11">2011</xref>; Del Fresno et al., <xref ref-type="bibr" rid="B25">2013</xref>).</p></sec><sec><title>Role of interferons in inflammasome activation and pyroptosis</title><p>Type I IFNs are innate immune effector molecules with strong pro-inflammatory activities, and have been shown to contribute to the high mortality rates in septic shock syndromes (Karaghiosoff et al., <xref ref-type="bibr" rid="B66">2003</xref>; Huys et al., <xref ref-type="bibr" rid="B54">2009</xref>). Type I IFNs also contribute to inflammasome-dependent caspase-1 activation leading to pro-inflammatory pyroptotic cell death (Figure <xref ref-type="fig" rid="F2">2</xref>) (Anand et al., <xref ref-type="bibr" rid="B3">2011</xref>; Franchi et al., <xref ref-type="bibr" rid="B38">2012</xref>). There have been multiple different inflammasomes identified that sense a diverse array of microbial- and damage-associated PAMPs. These include the Naip-Nlrc4 inflammasome (Mariathasan et al., <xref ref-type="bibr" rid="B84">2004</xref>; Kofoed and Vance, <xref ref-type="bibr" rid="B73">2011</xref>; Zhao et al., <xref ref-type="bibr" rid="B151">2011</xref>), the Nlrp1b inflammasome (Boyden and Dietrich, <xref ref-type="bibr" rid="B15">2006</xref>; Masters et al., <xref ref-type="bibr" rid="B88">2012</xref>), the Nlrp3 inflammasome (Kanneganti et al., <xref ref-type="bibr" rid="B64">2006b</xref>; Mariathasan et al., <xref ref-type="bibr" rid="B86">2006</xref>; Sutterwala et al., <xref ref-type="bibr" rid="B132">2006</xref>; Anand et al., <xref ref-type="bibr" rid="B3">2011</xref>), the Nlrp6 inflammasome (Elinav et al., <xref ref-type="bibr" rid="B31">2011</xref>), the Nlrp12 inflammasome (Vladimer et al., <xref ref-type="bibr" rid="B140">2012</xref>), the Aim2 inflammasome (Fernandes-Alnemri et al., <xref ref-type="bibr" rid="B34">2010</xref>; Jones et al., <xref ref-type="bibr" rid="B59">2010</xref>; Rathinam et al., <xref ref-type="bibr" rid="B113">2010</xref>; Sauer et al., <xref ref-type="bibr" rid="B124">2010</xref>), the RIG-I inflammasome (Poeck et al., <xref ref-type="bibr" rid="B108">2010</xref>; Pothlichet et al., <xref ref-type="bibr" rid="B110">2013</xref>), and the IFI16 inflammasome (Kerur et al., <xref ref-type="bibr" rid="B69">2011</xref>). Inflammasome-dependent casapase-1 activation and pyroptosis are associated with the production of mature IL-1&#x003b2; and IL-18 cytokines, which generates a pro-inflammatory environment in host tissues (Figure <xref ref-type="fig" rid="F2">2</xref>). Inflammasome-dependent pyroptosis shares features of both apoptosis and necrosis and is tightly regulated by distinct signaling pathways.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Role of type I interferons in inflammasome activation</bold>. Type I IFNs contribute to inflammasome activation through two different mechanisms. First, type I interferons are required for the upregulation of caspase-11, which contributes to activation of a non-canonical NLRP3 inflammasome in response to enteropathogenic bacteria, such as <italic>Citrobacter rodentium</italic> and <italic>Escherichia coli</italic>. Second, they prime the expression of inflammasome-forming NLRP3, RIG-I and AIM2 molecules for potentiating inflammasome activation.</p></caption><graphic xlink:href="fcimb-03-00077-g0002"/></fig><sec><title>NLRP3</title><p>NLRP3 is the most widely studied inflammasome and it requires two signals for its assembly into an active complex (Kanneganti, <xref ref-type="bibr" rid="B62">2010</xref>; Anand et al., <xref ref-type="bibr" rid="B3">2011</xref>). The first signal is TLR-dependent expression of NLRP3, while the second is often a damage related factor such as production of reactive oxygen species (ROS) or membrane damage (Anand et al., <xref ref-type="bibr" rid="B3">2011</xref>). Activated TLRs transfer signals through two major adapters that specify the downstream signaling pathways (Takeuchi and Akira, <xref ref-type="bibr" rid="B134">2010</xref>). The first one, MyD88 is required for NF-&#x003ba;B activation downstream of all TLRs except TLR3. The second, TRIF plays a dominant role in TLR3-dependent NF-&#x003ba;B activation and TLR4-mediated IRF signaling (Fitzgerald et al., <xref ref-type="bibr" rid="B35">2003a</xref>,<xref ref-type="bibr" rid="B36">b</xref>; Sato et al., <xref ref-type="bibr" rid="B123">2003</xref>; Yamamoto et al., <xref ref-type="bibr" rid="B150">2003</xref>).</p><p>Recently, our lab and other groups have shown that the TLR4-TRIF axis regulates caspase-11 expression and non-canonical Nlrp3 inflammasome-mediated host defense against enteropathogens, <italic>Escherichia coli</italic> (EHEC), <italic>Citrobacter rodentium</italic>, and <italic>Salmonella Typhimurium</italic> (Kayagaki et al., <xref ref-type="bibr" rid="B67">2011</xref>; Broz et al., <xref ref-type="bibr" rid="B19">2012</xref>; Gurung et al., <xref ref-type="bibr" rid="B47">2012</xref>; Rathinam et al., <xref ref-type="bibr" rid="B114">2012</xref>). Consistent with this, Sander et al. have reported that the gram-negative bacterium <italic>E. coli</italic> induces IFN-&#x003b2; and activates the Nlrp3 inflammasome in the absence of virulence factors other than microbial mRNA (Sander et al., <xref ref-type="bibr" rid="B122">2011</xref>). In addition, Rathinam et al. demonstrated that the IRF3-type I IFN-IFNAR-STAT-1 signaling pathway is indispensable for caspase-11 expression and activation of the Nlrp3 inflammasome and pyroptosis (Rathinam et al., <xref ref-type="bibr" rid="B114">2012</xref>). Furthermore, they demonstrated that IFN&#x003b2; treatment significantly increased pro-caspase-11 expression and that once induced, caspase-11 undergoes spontaneous activation. Broz et al. have observed that IFNAR-STAT-1 axis is important for caspase-11 activation, but not for its expression in <italic>Salmonella</italic> infected macrophages (Broz et al., <xref ref-type="bibr" rid="B19">2012</xref>). In a subsequent review, they speculated that type I IFN-dependent expression of a yet-unidentified host molecule may trigger caspase-11 activation or that a unknown bacterial signal is required (Broz and Monack, <xref ref-type="bibr" rid="B17">2013</xref>).</p><p>Two recent studies have revealed that several gram-negative bacteria, but not gram-positive bacteria, can activate the non-canonical Nlrp3 inflammasome and identified LPS as their common PAMP responsible for the activation of Caspase-11 (Hagar et al., <xref ref-type="bibr" rid="B48">2013</xref>; Kayagaki et al., <xref ref-type="bibr" rid="B68">2013</xref>). Both of these studies have shown that intracellular LPS is sufficient to induce the activation of caspase-11. Furthermore, these studies revealed that a sub-component of LPS, lipid A is sufficient to activate the casaspe-11-dependent non-canonical Nlrp3 inflammasome. They presented evidence that when transfected, intracellular LPS or lipid A could activate the non-canonical Nlrp3 inflammasome independent of TLR4 or the TLR4-associated lipid A-binding proteins MD1 and MD2 and even the TLR4 downstream signaling molecules TRIF and IFNAR receptor molecules. In contrast, a study by Guarda et al. reported that type I IFNs suppress Nlrp1 and Nlrp3 inflammasomes in a STAT1-dependent manner (Guarda et al., <xref ref-type="bibr" rid="B46">2011</xref>). Further studies are required to clarify the role of type I IFNs and their precise mechanisms in the regulation of inflammasome activation. Of particular importance is that the intracellular sensor of lipid A is yet to be identified.</p><p>Together, regardless of the exact mechanisms, type I IFNs have clearly emerged as crucial regulators of inflammasome activation and pyroptosis (Figure <xref ref-type="fig" rid="F2">2</xref>). Physiologically, caspase-11 triggered pyroptosis is required for surveillance against bacteria that enter the cytosol, such as the sifA mutant of <italic>S. Typhimurium</italic>, an sdhA mutant of <italic>Legionella pneumophila</italic> and <italic>Burkholderia</italic> species (Aachoui et al., <xref ref-type="bibr" rid="B1">2013</xref>). However, type I IFNs are known to be exploited by microbial pathogens to induce the death of immune cells and suppress host immune responses. In support of this, caspase-11-mediated cell death is responsible for pathology and detrimental effects <italic>in vivo</italic> (Wang et al., <xref ref-type="bibr" rid="B142">1998</xref>; Kayagaki et al., <xref ref-type="bibr" rid="B67">2011</xref>). For example, Broz et al. showed that wild type <italic>Salmonella</italic> induces caspase-11-mediated cell death in caspase-1-deficient mouse macrophages, and that caspase-11 increases the bacterial virulence and host cell susceptibility to infection (Broz et al., <xref ref-type="bibr" rid="B19">2012</xref>). In addition, <italic>Salmonella</italic> also exploits type I IFN signaling to induce the RIP1-RIP3-dependent necroptotic cell death pathway to kill macrophages (Lindgren et al., <xref ref-type="bibr" rid="B76">1996</xref>; Robinson et al., <xref ref-type="bibr" rid="B118">2012</xref>).</p></sec><sec><title>RIG-I and NLRP3</title><p>Viruses are by far the best-known inducers of type I IFNs and have also been recognized to induce activation of distinct inflammasomes, including those comprised of NLRP3, AIM2, and RIG-I. The first evidence of Nlrp3 inflammasome involvement in antiviral responses showed its role in sensing of both viral RNA and its analog poly(I:C) in mouse macrophages (Kanneganti et al., <xref ref-type="bibr" rid="B63">2006a</xref>,<xref ref-type="bibr" rid="B64">b</xref>). <italic>In vivo</italic>, Nlrp3 inflammasome activation protected mice from influenza infection (Allen et al., <xref ref-type="bibr" rid="B2">2009</xref>; Thomas et al., <xref ref-type="bibr" rid="B138">2009</xref>). Poeck et al. have reported that Rig-I from mouse macrophages senses cytoplasmic RNA viruses and assembles an inflammasome (Poeck et al., <xref ref-type="bibr" rid="B108">2010</xref>). More recently, RIG-I was reported to induce type I IFN through a MAVS/TRIM25/RNF135 signaling axis following influenza infection, and was shown to have profound effects on NLRP3 inflammasome activation and IL-1&#x003b2; secretion in human lung epithelial cells (Pothlichet et al., <xref ref-type="bibr" rid="B110">2013</xref>). Together, these studies demonstrate that RIG-I can itself assemble an inflammasome and also contributes toward, type I IFN-dependent potentiation of NLRP3 expression (Figure <xref ref-type="fig" rid="F2">2</xref>).</p></sec><sec><title>AIM2</title><p>The cytosolic bacteria <italic>Francisella novicida</italic> and <italic>Listeria</italic> both induce killing of myeloid and lymphoid cells in a manner dependent on Type I IFN signaling, an effect which has been shown to be detrimental to the host (Auerbuch et al., <xref ref-type="bibr" rid="B5">2004</xref>; Carrero et al., <xref ref-type="bibr" rid="B20">2004</xref>; O'Connell et al., <xref ref-type="bibr" rid="B98">2004</xref>; Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>). Several published studies have clearly established that both <italic>Listeria</italic> (Henry et al., <xref ref-type="bibr" rid="B50">2007</xref>; Warren et al., <xref ref-type="bibr" rid="B143">2008</xref>; Kim et al., <xref ref-type="bibr" rid="B71">2010</xref>; Tsuchiya et al., <xref ref-type="bibr" rid="B139">2010</xref>; Wu et al., <xref ref-type="bibr" rid="B148">2010</xref>) and <italic>Francisella</italic> (Henry and Monack, <xref ref-type="bibr" rid="B51">2007</xref>; Fernandes-Alnemri et al., <xref ref-type="bibr" rid="B34">2010</xref>; Jones et al., <xref ref-type="bibr" rid="B59">2010</xref>; Rathinam et al., <xref ref-type="bibr" rid="B113">2010</xref>) activate the Aim2 inflammasome and pyroptosis in mouse macrophages. Type I IFNs prime AIM2 expression (Kotredes and Gamero, <xref ref-type="bibr" rid="B74">2013</xref>) and potentiate cytosolic bacterial DNA recognition for inflammasome activation (Fernandes-Alnemri et al., <xref ref-type="bibr" rid="B34">2010</xref>). Although mice studies show that type I IFN dependent caspase-11 expression is important for the activation of the non-canonical Nlrp3 inflammasome (Kayagaki et al., <xref ref-type="bibr" rid="B67">2011</xref>; Gurung et al., <xref ref-type="bibr" rid="B47">2012</xref>; Rathinam et al., <xref ref-type="bibr" rid="B114">2012</xref>), it is not known if it is also required for AIM2 and RIG-I mediated caspase-1 activation or cell death.</p></sec></sec><sec sec-type="conclusions" id="s2"><title>Conclusions</title><p>IFNs were the first cytokines discovered to have immune regulatory capacity. Despite their clinical application in some treatment regimens, we still do not have a complete understanding of the mechanistic effects of IFNs required to further develop treatments that capitalize their full potential therapeutic effects. A vast amount of past research has been focused on the role of IFNs as anti-viral molecules with a limited number of studies for other microbial infections. Recent studies have clearly indicated a dual role for type I IFNs both in infectious and inflammatory diseases. Despite the potential benefits, it is often challenging to manipulate type I IFNs for therapeutic purposes due to their role in regulating the expression and activation of a huge number of downstream genes, often complicating the conclusions. Part of the problem is that types I IFNs exert differential immunomodulation on diverse cell types, environments, and varying physiological conditions. The pathogen- and host-mediated counter regulatory pathways further complicate IFN-induced responses in cell death and disease.</p><p>Recently, type I IFNs were recognized as crucial regulators of non-canonical NLRP3 inflammasome activation and pyroptosis. Although the majority of literature indicates a positive role for inflammasomes in anti-microbial host defense, recent reports indicate detrimental effects due to excessive cell death, inflammation, and collateral tissue damage in vital organs (Lupfer and Kanneganti, <xref ref-type="bibr" rid="B80">2012</xref>). A paradox exists, where inflammasomes intended to defend against cytoplasmic invaders by pyroptosis, which is predominantly protective <italic>in vitro</italic>, however in <italic>in vivo</italic>, if exceeds a certain level, can lead to cell and tissue damage and organ failure resulting in negative outcomes. The paradox for type-I IFNs is that their ability to inhibit microbial spread by inducing cell death is counteracted by apoptotic depletion of immune cells and inhibiting anti-microbial immune responses leading to immune suppression. Future research should explore the detailed molecular mechanisms that are responsible for type I IFN-dependent cell death and inflammasomes activation in the context of immunity and immunopathology. These findings may lead to better-targeted therapeutic interventions to treat inflammatory and infectious diseases.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We apologize to the numerous investigators whose papers could not be cited because of space limitations. This work was supported by National Institutes of Health grants (AR056296, CA163507 and AI101935), and the American Lebanese Syrian Associated Charities (ALSAC) to Thirumala-Devi Kanneganti.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aachoui</surname><given-names>Y.</given-names></name><name><surname>Leaf</surname><given-names>I. A.</given-names></name><name><surname>Hagar</surname><given-names>J. A.</given-names></name><name><surname>Fontana</surname><given-names>M. F.</given-names></name><name><surname>Campos</surname><given-names>C. G.</given-names></name><name><surname>Zak</surname><given-names>D. E.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Caspase-11 protects against bacteria that escape the vacuole</article-title>. <source>Science</source>
<volume>339</volume>, <fpage>975</fpage>&#x02013;<lpage>978</lpage>
<pub-id pub-id-type="doi">10.1126/science.1230751</pub-id><?supplied-pmid 23348507?><pub-id pub-id-type="pmid">23348507</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>I. C.</given-names></name><name><surname>Scull</surname><given-names>M. A.</given-names></name><name><surname>Moore</surname><given-names>C. B.</given-names></name><name><surname>Holl</surname><given-names>E. K.</given-names></name><name><surname>McElvania-TeKippe</surname><given-names>E.</given-names></name><name><surname>Taxman</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The NLRP3 inflammasome mediates <italic>in vivo</italic> innate immunity to influenza A virus through recognition of viral RNA</article-title>. <source>Immunity</source>
<volume>30</volume>, <fpage>556</fpage>&#x02013;<lpage>565</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.005</pub-id><?supplied-pmid 19362020?><pub-id pub-id-type="pmid">19362020</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P. K.</given-names></name><name><surname>Malireddi</surname><given-names>R. K.</given-names></name><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of the nlrp3 inflammasome in microbial infection</article-title>. <source>Front. Microbiol</source>. <volume>2</volume>:<fpage>12</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2011.00012</pub-id><?supplied-pmid 21687408?><pub-id pub-id-type="pmid">21687408</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arlehamn</surname><given-names>C. S.</given-names></name><name><surname>Evans</surname><given-names>T. J.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Pseudomonas aeruginosa</italic> pilin activates the inflammasome</article-title>. <source>Cell Microbiol</source>. <volume>13</volume>, <fpage>388</fpage>&#x02013;<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01541.x</pub-id><?supplied-pmid 20955240?><pub-id pub-id-type="pmid">20955240</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V.</given-names></name><name><surname>Brockstedt</surname><given-names>D. G.</given-names></name><name><surname>Meyer-Morse</surname><given-names>N.</given-names></name><name><surname>O'Riordan</surname><given-names>M.</given-names></name><name><surname>Portnoy</surname><given-names>D. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogenes</italic></article-title>. <source>J. Exp. Med</source>. <volume>200</volume>, <fpage>527</fpage>&#x02013;<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20040976</pub-id><?supplied-pmid 15302899?><pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname><given-names>S.</given-names></name><name><surname>Roberts</surname><given-names>P. C.</given-names></name><name><surname>Kipperman</surname><given-names>T.</given-names></name><name><surname>Bhalla</surname><given-names>K. N.</given-names></name><name><surname>Compans</surname><given-names>R. W.</given-names></name><name><surname>Archer</surname><given-names>D. R.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway</article-title>. <source>J. Virol</source>. <volume>74</volume>, <fpage>1513</fpage>&#x02013;<lpage>1523</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.74.3.1513-1523.2000</pub-id><?supplied-pmid 10627563?><pub-id pub-id-type="pmid">10627563</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergsbaken</surname><given-names>T.</given-names></name><name><surname>Fink</surname><given-names>S. L.</given-names></name><name><surname>Cookson</surname><given-names>B. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Pyroptosis: host cell death and inflammation</article-title>. <source>Nat. Rev. Microbiol</source>. <volume>7</volume>, <fpage>99</fpage>&#x02013;<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2070</pub-id><?supplied-pmid 19148178?><pub-id pub-id-type="pmid">19148178</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<volume>466</volume>, <fpage>973</fpage>&#x02013;<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>C.</given-names></name><name><surname>Malara</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>A.</given-names></name><name><surname>Signorino</surname><given-names>G.</given-names></name><name><surname>Cardile</surname><given-names>F.</given-names></name><name><surname>Midiri</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Recognition of fungal RNA by TLR7 has a non-redundant role in host defense against experimental candidiasis</article-title>. <source>Eur. J. Immunol</source>. <volume>42</volume>, <fpage>2632</fpage>&#x02013;<lpage>2643</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201242532</pub-id><?supplied-pmid 22777843?><pub-id pub-id-type="pmid">22777843</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>C.</given-names></name><name><surname>Midiri</surname><given-names>A.</given-names></name><name><surname>Gambuzza</surname><given-names>M.</given-names></name><name><surname>Gerace</surname><given-names>E.</given-names></name><name><surname>Falduto</surname><given-names>M.</given-names></name><name><surname>Galbo</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis</article-title>. <source>J. Immunol</source>. <volume>181</volume>, <fpage>566</fpage>&#x02013;<lpage>573</lpage>
<?supplied-pmid 18566423?><pub-id pub-id-type="pmid">18566423</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>C.</given-names></name><name><surname>Signorino</surname><given-names>G.</given-names></name><name><surname>Costa</surname><given-names>A.</given-names></name><name><surname>Midiri</surname><given-names>A.</given-names></name><name><surname>Gerace</surname><given-names>E.</given-names></name><name><surname>Galbo</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Recognition of yeast nucleic acids triggers a host-protective type I interferon response</article-title>. <source>Eur. J. Immunol</source>. <volume>41</volume>, <fpage>1969</fpage>&#x02013;<lpage>1979</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201141490</pub-id><?supplied-pmid 21480215?><pub-id pub-id-type="pmid">21480215</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchonnet</surname><given-names>F.</given-names></name><name><surname>Boechat</surname><given-names>N.</given-names></name><name><surname>Bonay</surname><given-names>M.</given-names></name><name><surname>Hance</surname><given-names>A. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Alpha/beta interferon impairs the ability of human macrophages to control growth of <italic>Mycobacterium bovis</italic> BCG</article-title>. <source>Infect. Immun</source>. <volume>70</volume>, <fpage>3020</fpage>&#x02013;<lpage>3025</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.70.6.3020-3025.2002</pub-id><?supplied-pmid 12010993?><pub-id pub-id-type="pmid">12010993</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgeois</surname><given-names>C.</given-names></name><name><surname>Majer</surname><given-names>O.</given-names></name><name><surname>Frohner</surname><given-names>I. E.</given-names></name><name><surname>Lesiak-Markowicz</surname><given-names>I.</given-names></name><name><surname>Hildering</surname><given-names>K. S.</given-names></name><name><surname>Glaser</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Conventional dendritic cells mount a type I IFN response against <italic>Candida</italic> spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling</article-title>. <source>J. Immunol</source>. <volume>186</volume>, <fpage>3104</fpage>&#x02013;<lpage>3112</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1002599</pub-id><?supplied-pmid 21282509?><pub-id pub-id-type="pmid">21282509</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowie</surname><given-names>A. G.</given-names></name><name><surname>Unterholzner</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Viral evasion and subversion of pattern-recognition receptor signalling</article-title>. <source>Nat. Rev. Immunol</source>. <volume>8</volume>, <fpage>911</fpage>&#x02013;<lpage>922</lpage>
<pub-id pub-id-type="doi">10.1038/nri2436</pub-id><?supplied-pmid 18989317?><pub-id pub-id-type="pmid">18989317</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyden</surname><given-names>E. D.</given-names></name><name><surname>Dietrich</surname><given-names>W. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin</article-title>. <source>Nat. Genet</source>. <volume>38</volume>, <fpage>240</fpage>&#x02013;<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1038/ng1724</pub-id><?supplied-pmid 16429160?><pub-id pub-id-type="pmid">16429160</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>G. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Innate antifungal immunity: the key role of phagocytes</article-title>. <source>Annu. Rev. Immunol</source>. <volume>29</volume>, <fpage>1</fpage>&#x02013;<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101229</pub-id><?supplied-pmid 20936972?><pub-id pub-id-type="pmid">20936972</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Non-canonical inflammasomes: caspase-11 activation and effector mechanisms</article-title>. <source>PLoS Pathog</source>. <volume>9</volume>:<fpage>e1003144</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003144</pub-id>
<?supplied-pmid 23762026?><pub-id pub-id-type="pmid">23468620</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>Lamkanfi</surname><given-names>M.</given-names></name><name><surname>Mariathasan</surname><given-names>S.</given-names></name><name><surname>Dixit</surname><given-names>V. M.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella</article-title>. <source>J. Exp. Med</source>. <volume>207</volume>, <fpage>1745</fpage>&#x02013;<lpage>1755</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20100257</pub-id><?supplied-pmid 20603313?><pub-id pub-id-type="pmid">20603313</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P.</given-names></name><name><surname>Ruby</surname><given-names>T.</given-names></name><name><surname>Belhocine</surname><given-names>K.</given-names></name><name><surname>Bouley</surname><given-names>D. M.</given-names></name><name><surname>Kayagaki</surname><given-names>N.</given-names></name><name><surname>Dixit</surname><given-names>V. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1</article-title>. <source>Nature</source>
<volume>490</volume>, <fpage>288</fpage>&#x02013;<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature11419</pub-id><?supplied-pmid 22895188?><pub-id pub-id-type="pmid">22895188</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>J. A.</given-names></name><name><surname>Calderon</surname><given-names>B.</given-names></name><name><surname>Unanue</surname><given-names>E. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection</article-title>. <source>J. Exp. Med</source>. <volume>200</volume>, <fpage>535</fpage>&#x02013;<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20040769</pub-id><?supplied-pmid 15302900?><pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrigan</surname><given-names>S. O.</given-names></name><name><surname>Junkins</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>Y. J.</given-names></name><name><surname>Macneil</surname><given-names>A.</given-names></name><name><surname>Richardson</surname><given-names>C.</given-names></name><name><surname>Johnston</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>IFN regulatory factor 3 contributes to the host response during <italic>Pseudomonas aeruginosa</italic> lung infection in mice</article-title>. <source>J. Immunol</source>. <volume>185</volume>, <fpage>3602</fpage>&#x02013;<lpage>3609</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903429</pub-id><?supplied-pmid 20720199?><pub-id pub-id-type="pmid">20720199</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>T. S.</given-names></name><name><surname>Prince</surname><given-names>A. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Activation of inflammasome signaling mediates pathology of acute <italic>P. aeruginosa</italic> pneumonia</article-title>. <source>J. Clin. Invest</source>. <volume>123</volume>, <fpage>1630</fpage>&#x02013;<lpage>1637</lpage>
<pub-id pub-id-type="doi">10.1172/JCI66142</pub-id><?supplied-pmid 23478406?><pub-id pub-id-type="pmid">23478406</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craven</surname><given-names>R. R.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Allen</surname><given-names>I. C.</given-names></name><name><surname>Gris</surname><given-names>D.</given-names></name><name><surname>Bubeck Wardenburg</surname><given-names>J.</given-names></name><name><surname>McElvania-Tekippe</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title><italic>Staphylococcus aureus</italic> alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells</article-title>. <source>PLoS ONE</source>
<volume>4</volume>:<fpage>e7446</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0007446</pub-id><?supplied-pmid 19826485?><pub-id pub-id-type="pmid">19826485</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>M. Z.</given-names></name><name><surname>Daum</surname><given-names>R. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Community-associated methicillin-resistant <italic>Staphylococcus aureus</italic>: epidemiology and clinical consequences of an emerging epidemic</article-title>. <source>Clin. Microbiol. Rev</source>. <volume>23</volume>, <fpage>616</fpage>&#x02013;<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00081-09</pub-id><?supplied-pmid 20610826?><pub-id pub-id-type="pmid">20610826</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Fresno</surname><given-names>C.</given-names></name><name><surname>Soulat</surname><given-names>D.</given-names></name><name><surname>Roth</surname><given-names>S.</given-names></name><name><surname>Blazek</surname><given-names>K.</given-names></name><name><surname>Udalova</surname><given-names>I.</given-names></name><name><surname>Sancho</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to</article-title>
<source>C. albicans. Immunity</source>
<volume>38</volume>, <fpage>1176</fpage>&#x02013;<lpage>1186</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2013.05.010</pub-id><?supplied-pmid 23770228?><pub-id pub-id-type="pmid">23770228</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Der</surname><given-names>S. D.</given-names></name><name><surname>Yang</surname><given-names>Y. L.</given-names></name><name><surname>Weissmann</surname><given-names>C.</given-names></name><name><surname>Williams</surname><given-names>B. R.</given-names></name></person-group> (<year>1997</year>). <article-title>A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>94</volume>, <fpage>3279</fpage>&#x02013;<lpage>3283</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.7.3279</pub-id><?supplied-pmid 9096384?><pub-id pub-id-type="pmid">9096384</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Der</surname><given-names>S. D.</given-names></name><name><surname>Zhou</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>B. R.</given-names></name><name><surname>Silverman</surname><given-names>R. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>95</volume>, <fpage>15623</fpage>&#x02013;<lpage>15628</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.95.26.15623</pub-id><?supplied-pmid 9861020?><pub-id pub-id-type="pmid">9861020</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Veer</surname><given-names>M. J.</given-names></name><name><surname>Holko</surname><given-names>M.</given-names></name><name><surname>Frevel</surname><given-names>M.</given-names></name><name><surname>Walker</surname><given-names>E.</given-names></name><name><surname>Der</surname><given-names>S.</given-names></name><name><surname>Paranjape</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Functional classification of interferon-stimulated genes identified using microarrays</article-title>. <source>J. Leukoc. Biol</source>. <volume>69</volume>, <fpage>912</fpage>&#x02013;<lpage>920</lpage>
<?supplied-pmid 11404376?><pub-id pub-id-type="pmid">11404376</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Guerra</surname><given-names>M.</given-names></name><name><surname>Rivas</surname><given-names>C.</given-names></name><name><surname>Esteban</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells</article-title>. <source>Virology</source>
<volume>236</volume>, <fpage>354</fpage>&#x02013;<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1006/viro.1997.8719</pub-id><?supplied-pmid 9325243?><pub-id pub-id-type="pmid">9325243</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>T. C.</given-names></name><name><surname>Meselson</surname><given-names>M.</given-names></name><name><surname>Guillemin</surname><given-names>J.</given-names></name><name><surname>Hanna</surname><given-names>P. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Anthrax</article-title>. <source>N. Engl. J. Med</source>. <volume>341</volume>, <fpage>815</fpage>&#x02013;<lpage>826</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199909093411107</pub-id><?supplied-pmid 10477781?><pub-id pub-id-type="pmid">10477781</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elinav</surname><given-names>E.</given-names></name><name><surname>Strowig</surname><given-names>T.</given-names></name><name><surname>Kau</surname><given-names>A. L.</given-names></name><name><surname>Henao-Mejia</surname><given-names>J.</given-names></name><name><surname>Thaiss</surname><given-names>C. A.</given-names></name><name><surname>Booth</surname><given-names>C. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis</article-title>. <source>Cell</source>
<volume>145</volume>, <fpage>745</fpage>&#x02013;<lpage>757</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.04.022</pub-id><?supplied-pmid 21565393?><pub-id pub-id-type="pmid">21565393</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezelle</surname><given-names>H. J.</given-names></name><name><surname>Balachandran</surname><given-names>S.</given-names></name><name><surname>Sicheri</surname><given-names>F.</given-names></name><name><surname>Polyak</surname><given-names>S. J.</given-names></name><name><surname>Barber</surname><given-names>G. N.</given-names></name></person-group> (<year>2001</year>). <article-title>Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A</article-title>. <source>Virology</source>
<volume>281</volume>, <fpage>124</fpage>&#x02013;<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1006/viro.2001.0815</pub-id><?supplied-pmid 11222103?><pub-id pub-id-type="pmid">11222103</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>K.</given-names></name><name><surname>Sawa</surname><given-names>T.</given-names></name><name><surname>Ajayi</surname><given-names>T.</given-names></name><name><surname>Fujimoto</surname><given-names>J.</given-names></name><name><surname>Moriyama</surname><given-names>K.</given-names></name><name><surname>Shime</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>TLR4 signaling is essential for survival in acute lung injury induced by virulent <italic>Pseudomonas aeruginosa</italic> secreting type III secretory toxins</article-title>. <source>Respir. Res</source>. <volume>5</volume>, <fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-5-1</pub-id><?supplied-pmid 15040820?><pub-id pub-id-type="pmid">15040820</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes-Alnemri</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>J. W.</given-names></name><name><surname>Juliana</surname><given-names>C.</given-names></name><name><surname>Solorzano</surname><given-names>L.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The AIM2 inflammasome is critical for innate immunity to <italic>Francisella tularensis</italic></article-title>. <source>Nat. Immunol</source>. <volume>11</volume>, <fpage>385</fpage>&#x02013;<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1859</pub-id><?supplied-pmid 20351693?><pub-id pub-id-type="pmid">20351693</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name><name><surname>McWhirter</surname><given-names>S. M.</given-names></name><name><surname>Faia</surname><given-names>K. L.</given-names></name><name><surname>Rowe</surname><given-names>D. C.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><name><surname>Golenbock</surname><given-names>D. T.</given-names></name><etal/></person-group> (<year>2003a</year>). <article-title>IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway</article-title>. <source>Nat. Immunol</source>. <volume>4</volume>, <fpage>491</fpage>&#x02013;<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1038/ni921</pub-id><?supplied-pmid 12692549?><pub-id pub-id-type="pmid">12692549</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name><name><surname>Rowe</surname><given-names>D. C.</given-names></name><name><surname>Barnes</surname><given-names>B. J.</given-names></name><name><surname>Caffrey</surname><given-names>D. R.</given-names></name><name><surname>Visintin</surname><given-names>A.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2003b</year>). <article-title>LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF</article-title>. <source>J. Exp. Med</source>. <volume>198</volume>, <fpage>1043</fpage>&#x02013;<lpage>1055</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20031023</pub-id><?supplied-pmid 14517278?><pub-id pub-id-type="pmid">14517278</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franchi</surname><given-names>L.</given-names></name><name><surname>Amer</surname><given-names>A.</given-names></name><name><surname>Body-Malapel</surname><given-names>M.</given-names></name><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name><name><surname>Ozoren</surname><given-names>N.</given-names></name><name><surname>Jagirdar</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages</article-title>. <source>Nat. Immunol</source>. <volume>7</volume>, <fpage>576</fpage>&#x02013;<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1038/ni1346</pub-id><?supplied-pmid 16648852?><pub-id pub-id-type="pmid">16648852</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franchi</surname><given-names>L.</given-names></name><name><surname>Munoz-Planillo</surname><given-names>R.</given-names></name><name><surname>Nunez</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Sensing and reacting to microbes through the inflammasomes</article-title>. <source>Nat. Immunol</source>. <volume>13</volume>, <fpage>325</fpage>&#x02013;<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2231</pub-id><?supplied-pmid 22430785?><pub-id pub-id-type="pmid">22430785</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuertes Marraco</surname><given-names>S. A.</given-names></name><name><surname>Scott</surname><given-names>C. L.</given-names></name><name><surname>Bouillet</surname><given-names>P.</given-names></name><name><surname>Ives</surname><given-names>A.</given-names></name><name><surname>Masina</surname><given-names>S.</given-names></name><name><surname>Vremec</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC <italic>in vivo</italic></article-title>. <source>PLoS ONE</source>
<fpage>6</fpage>:<fpage>e20189</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0020189</pub-id><?supplied-pmid 21674051?><pub-id pub-id-type="pmid">21674051</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Kepp</surname><given-names>O.</given-names></name><name><surname>Morselli</surname><given-names>E.</given-names></name><name><surname>Vitale</surname><given-names>I.</given-names></name><name><surname>Senovilla</surname><given-names>L.</given-names></name><name><surname>Pinti</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Viral strategies for the evasion of immunogenic cell death</article-title>. <source>J. Intern. Med</source>. <volume>267</volume>, <fpage>526</fpage>&#x02013;<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2796.2010.02223.x</pub-id><?supplied-pmid 20433579?><pub-id pub-id-type="pmid">20433579</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavrilin</surname><given-names>M. A.</given-names></name><name><surname>Wewers</surname><given-names>M. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Francisella recognition by inflammasomes: differences between mice and men</article-title>. <source>Front. Microbiol</source>. <volume>2</volume>:<fpage>11</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2011.00011</pub-id><?supplied-pmid 21687407?><pub-id pub-id-type="pmid">21687407</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S.</given-names></name><name><surname>Casarini</surname><given-names>M.</given-names></name><name><surname>Alemanno</surname><given-names>L.</given-names></name><name><surname>Galluccio</surname><given-names>G.</given-names></name><name><surname>Mattia</surname><given-names>P.</given-names></name><name><surname>Pedicelli</surname><given-names>G.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis</article-title>. <source>Am. J. Respir. Crit. Care Med</source>. <volume>158</volume>, <fpage>1156</fpage>&#x02013;<lpage>1162</lpage>
<pub-id pub-id-type="doi">10.1164/ajrccm.158.4.9803065</pub-id><?supplied-pmid 9769275?><pub-id pub-id-type="pmid">9769275</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>J. A.</given-names></name><name><surname>Hoshino</surname><given-names>Y.</given-names></name><name><surname>Jones</surname><given-names>M. B.</given-names></name><name><surname>Hoshino</surname><given-names>S.</given-names></name><name><surname>Nolan</surname><given-names>A.</given-names></name><name><surname>Weiden</surname><given-names>M. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax</article-title>. <source>PLoS ONE</source>
<volume>2</volume>:<fpage>e736</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0000736</pub-id><?supplied-pmid 17710136?><pub-id pub-id-type="pmid">17710136</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Navajas</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>David</surname><given-names>M.</given-names></name><name><surname>Raz</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Immunomodulatory functions of type I interferons</article-title>. <source>Nat. Rev. Immunol</source>. <volume>12</volume>, <fpage>125</fpage>&#x02013;<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1038/nri3133</pub-id><?supplied-pmid 22222875?><pub-id pub-id-type="pmid">22222875</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>S. M.</given-names></name><name><surname>Davis</surname><given-names>B. K.</given-names></name><name><surname>West</surname><given-names>J. A.</given-names></name><name><surname>Taxman</surname><given-names>D. J.</given-names></name><name><surname>Matsuzawa</surname><given-names>S.</given-names></name><name><surname>Reed</surname><given-names>J. C.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Discovery of a viral NLR homolog that inhibits the inflammasome</article-title>. <source>Science</source>
<volume>331</volume>, <fpage>330</fpage>&#x02013;<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1126/science.1199478</pub-id><?supplied-pmid 21252346?><pub-id pub-id-type="pmid">21252346</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Staehli</surname><given-names>F.</given-names></name><name><surname>Tardivel</surname><given-names>A.</given-names></name><name><surname>Mattmann</surname><given-names>C.</given-names></name><name><surname>Forster</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title>. <source>Immunity</source>
<volume>34</volume>, <fpage>213</fpage>&#x02013;<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id><?supplied-pmid 21349431?><pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurung</surname><given-names>P.</given-names></name><name><surname>Malireddi</surname><given-names>R. K.</given-names></name><name><surname>Anand</surname><given-names>P. K.</given-names></name><name><surname>Demon</surname><given-names>D.</given-names></name><name><surname>Walle</surname><given-names>L. V.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens</article-title>. <source>J. Biol. Chem</source>. <volume>287</volume>, <fpage>34474</fpage>&#x02013;<lpage>34483</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.401406</pub-id><?supplied-pmid 22898816?><pub-id pub-id-type="pmid">22898816</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagar</surname><given-names>J. A.</given-names></name><name><surname>Powell</surname><given-names>D. A.</given-names></name><name><surname>Aachoui</surname><given-names>Y.</given-names></name><name><surname>Ernst</surname><given-names>R. K.</given-names></name><name><surname>Miao</surname><given-names>E. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock</article-title>. <source>Science</source>
<volume>341</volume>, <fpage>1250</fpage>&#x02013;<lpage>1253</lpage>
<pub-id pub-id-type="doi">10.1126/science.1240988</pub-id><?supplied-pmid 24031018?><pub-id pub-id-type="pmid">24031018</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havell</surname><given-names>E. A.</given-names></name></person-group> (<year>1986</year>). <article-title>Augmented induction of interferons during <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J. Infect. Dis</source>. <volume>153</volume>, <fpage>960</fpage>&#x02013;<lpage>969</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/153.5.960</pub-id><?supplied-pmid 3084667?><pub-id pub-id-type="pmid">3084667</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Brotcke</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>D. S.</given-names></name><name><surname>Thompson</surname><given-names>L. J.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Type I interferon signaling is required for activation of the inflammasome during Francisella infection</article-title>. <source>J. Exp. Med</source>. <volume>204</volume>, <fpage>987</fpage>&#x02013;<lpage>994</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20062665</pub-id><?supplied-pmid 17452523?><pub-id pub-id-type="pmid">17452523</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Activation of the inflammasome upon <italic>Francisella tularensis</italic> infection: interplay of innate immune pathways and virulence factors</article-title>. <source>Cell Microbiol</source>. <volume>9</volume>, <fpage>2543</fpage>&#x02013;<lpage>2551</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.01022.x</pub-id><?supplied-pmid 17662071?><pub-id pub-id-type="pmid">17662071</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertzog</surname><given-names>P. J.</given-names></name><name><surname>Williams</surname><given-names>B. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Fine tuning type i interferon responses</article-title>. <source>Cytokine Growth Factor Rev</source>. <volume>24</volume>, <fpage>217</fpage>&#x02013;<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1016/j.cytogfr.2013.04.002</pub-id><?supplied-pmid 23711406?><pub-id pub-id-type="pmid">23711406</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogner</surname><given-names>K.</given-names></name><name><surname>Wolff</surname><given-names>T.</given-names></name><name><surname>Pleschka</surname><given-names>S.</given-names></name><name><surname>Plog</surname><given-names>S.</given-names></name><name><surname>Gruber</surname><given-names>A. D.</given-names></name><name><surname>Kalinke</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia</article-title>. <source>PLoS Pathog</source>. <volume>9</volume>:<fpage>e1003188</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003188</pub-id><?supplied-pmid 23468627?><pub-id pub-id-type="pmid">23468627</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huys</surname><given-names>L.</given-names></name><name><surname>Van Hauwermeiren</surname><given-names>F.</given-names></name><name><surname>Dejager</surname><given-names>L.</given-names></name><name><surname>Dejonckheere</surname><given-names>E.</given-names></name><name><surname>Lienenklaus</surname><given-names>S.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Type I interferon drives tumor necrosis factor-induced lethal shock</article-title>. <source>J. Exp. Med</source>. <volume>206</volume>, <fpage>1873</fpage>&#x02013;<lpage>1882</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20090213</pub-id><?supplied-pmid 19687227?><pub-id pub-id-type="pmid">19687227</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglis</surname><given-names>D. O.</given-names></name><name><surname>Berkes</surname><given-names>C. A.</given-names></name><name><surname>Hocking Murray</surname><given-names>D. R.</given-names></name><name><surname>Sil</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Conidia but not yeast cells of the fungal pathogen <italic>Histoplasma capsulatum</italic> trigger a type I interferon innate immune response in murine macrophages</article-title>. <source>Infect. Immun</source>. <volume>78</volume>, <fpage>3871</fpage>&#x02013;<lpage>3882</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00204-10</pub-id>
<?supplied-pmid 22447608?><pub-id pub-id-type="pmid">20605974</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Barber</surname><given-names>G. N.</given-names></name></person-group> (<year>2009</year>). <article-title>STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity</article-title>. <source>Nature</source>
<volume>461</volume>, <fpage>788</fpage>&#x02013;<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1038/nature08476</pub-id><?supplied-pmid 19776740?><pub-id pub-id-type="pmid">19776740</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>J.</given-names></name><name><surname>Balish</surname><given-names>E.</given-names></name></person-group> (<year>1993</year>). <article-title>Enhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I. C)-induced interferon</article-title>. <source>Infect. Immun</source>. <volume>61</volume>, <fpage>3530</fpage>&#x02013;<lpage>3532</lpage>
<?supplied-pmid 8335384?><pub-id pub-id-type="pmid">8335384</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>J.</given-names></name><name><surname>Vazquez-Torres</surname><given-names>A.</given-names></name><name><surname>Balish</surname><given-names>E.</given-names></name></person-group> (<year>1992</year>). <article-title>Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis</article-title>. <source>Infect. Immun</source>. <volume>60</volume>, <fpage>4549</fpage>&#x02013;<lpage>4557</lpage>
<?supplied-pmid 1383152?><pub-id pub-id-type="pmid">1383152</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J. W.</given-names></name><name><surname>Kayagaki</surname><given-names>N.</given-names></name><name><surname>Broz</surname><given-names>P.</given-names></name><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>O'Rourke</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Absent in melanoma 2 is required for innate immune recognition of <italic>Francisella tularensis. Proc.</italic></article-title>
<source>Natl. Acad. Sci. U.S.A</source>. <volume>107</volume>, <fpage>9771</fpage>&#x02013;<lpage>9776</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1003738107</pub-id><?supplied-pmid 20457908?><pub-id pub-id-type="pmid">20457908</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>E. A.</given-names></name><name><surname>Popper</surname><given-names>S. J.</given-names></name><name><surname>Falkow</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>Streptococcus pneumoniae</italic> nasopharyngeal colonization induces type I interferons and interferon-induced gene expression</article-title>. <source>BMC Genomics</source>
<volume>10</volume>:<fpage>404</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-10-404</pub-id><?supplied-pmid 19712482?><pub-id pub-id-type="pmid">19712482</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminskyy</surname><given-names>V.</given-names></name><name><surname>Zhivotovsky</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>To kill or be killed: how viruses interact with the cell death machinery</article-title>. <source>J. Intern. Med</source>. <volume>267</volume>, <fpage>473</fpage>&#x02013;<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2796.2010.02222.x</pub-id><?supplied-pmid 20433575?><pub-id pub-id-type="pmid">20433575</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Central roles of NLRs and inflammasomes in viral infection</article-title>. <source>Nat. Rev. Immunol</source>. <volume>10</volume>, <fpage>688</fpage>&#x02013;<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1038/nri2851</pub-id><?supplied-pmid 20847744?><pub-id pub-id-type="pmid">20847744</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name><name><surname>Body-Malapel</surname><given-names>M.</given-names></name><name><surname>Amer</surname><given-names>A.</given-names></name><name><surname>Park</surname><given-names>J. H.</given-names></name><name><surname>Whitfield</surname><given-names>J.</given-names></name><name><surname>Franchi</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2006a</year>). <article-title>Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA</article-title>. <source>J. Biol. Chem</source>. <volume>281</volume>, <fpage>36560</fpage>&#x02013;<lpage>36568</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M607594200</pub-id><?supplied-pmid 17008311?><pub-id pub-id-type="pmid">17008311</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name><name><surname>Ozoren</surname><given-names>N.</given-names></name><name><surname>Body-Malapel</surname><given-names>M.</given-names></name><name><surname>Amer</surname><given-names>A.</given-names></name><name><surname>Park</surname><given-names>J. H.</given-names></name><name><surname>Franchi</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2006b</year>). <article-title>Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3</article-title>. <source>Nature</source>
<volume>440</volume>, <fpage>233</fpage>&#x02013;<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1038/nature04517</pub-id><?supplied-pmid 16407888?><pub-id pub-id-type="pmid">16407888</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Kyme</surname><given-names>P.</given-names></name><name><surname>Wolf</surname><given-names>A. J.</given-names></name><name><surname>Becker</surname><given-names>C. A.</given-names></name><name><surname>Tseng</surname><given-names>C. W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Failure to induce IFN-beta production during <italic>Staphylococcus aureus</italic> infection contributes to pathogenicity</article-title>. <source>J. Immunol</source>. <volume>189</volume>, <fpage>4537</fpage>&#x02013;<lpage>4545</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1201111</pub-id><?supplied-pmid 23008447?><pub-id pub-id-type="pmid">23008447</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaghiosoff</surname><given-names>M.</given-names></name><name><surname>Steinborn</surname><given-names>R.</given-names></name><name><surname>Kovarik</surname><given-names>P.</given-names></name><name><surname>Kriegshauser</surname><given-names>G.</given-names></name><name><surname>Baccarini</surname><given-names>M.</given-names></name><name><surname>Donabauer</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock</article-title>. <source>Nat. Immunol</source>. <volume>4</volume>, <fpage>471</fpage>&#x02013;<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1038/ni910</pub-id><?supplied-pmid 12679810?><pub-id pub-id-type="pmid">12679810</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayagaki</surname><given-names>N.</given-names></name><name><surname>Warming</surname><given-names>S.</given-names></name><name><surname>Lamkanfi</surname><given-names>M.</given-names></name><name><surname>Van de Walle</surname><given-names>L.</given-names></name><name><surname>Louie</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Non-canonical inflammasome activation targets caspase-11</article-title>. <source>Nature</source>
<volume>479</volume>, <fpage>117</fpage>&#x02013;<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1038/nature10558</pub-id><?supplied-pmid 22002608?><pub-id pub-id-type="pmid">22002608</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayagaki</surname><given-names>N.</given-names></name><name><surname>Wong</surname><given-names>M. T.</given-names></name><name><surname>Stowe</surname><given-names>I. B.</given-names></name><name><surname>Ramani</surname><given-names>S. R.</given-names></name><name><surname>Gonzalez</surname><given-names>L. C.</given-names></name><name><surname>Akashi-Takamura</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Non-canonical inflammasome activation by intracellular LPS independent of TLR4</article-title>. <source>Science</source>
<volume>341</volume>, <fpage>1246</fpage>&#x02013;<lpage>1249</lpage>
<pub-id pub-id-type="doi">10.1126/science.1240248</pub-id><?supplied-pmid 23887873?><pub-id pub-id-type="pmid">23887873</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerur</surname><given-names>N.</given-names></name><name><surname>Veettil</surname><given-names>M. V.</given-names></name><name><surname>Sharma-Walia</surname><given-names>N.</given-names></name><name><surname>Bottero</surname><given-names>V.</given-names></name><name><surname>Sadagopan</surname><given-names>S.</given-names></name><name><surname>Otageri</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection</article-title>. <source>Cell Host Microbe</source>
<volume>9</volume>, <fpage>363</fpage>&#x02013;<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2011.04.008</pub-id><?supplied-pmid 21575908?><pub-id pub-id-type="pmid">21575908</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kibler</surname><given-names>K. V.</given-names></name><name><surname>Shors</surname><given-names>T.</given-names></name><name><surname>Perkins</surname><given-names>K. B.</given-names></name><name><surname>Zeman</surname><given-names>C. C.</given-names></name><name><surname>Banaszak</surname><given-names>M. P.</given-names></name><name><surname>Biesterfeldt</surname><given-names>J.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells</article-title>. <source>J. Virol</source>. <volume>71</volume>, <fpage>1992</fpage>&#x02013;<lpage>2003</lpage>
<?supplied-pmid 9032331?><pub-id pub-id-type="pmid">9032331</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Bauernfeind</surname><given-names>F.</given-names></name><name><surname>Ablasser</surname><given-names>A.</given-names></name><name><surname>Hartmann</surname><given-names>G.</given-names></name><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title><italic>Listeria monocytogenes</italic> is sensed by the NLRP3 and AIM2 inflammasome</article-title>. <source>Eur. J. Immunol</source>. <volume>40</volume>, <fpage>1545</fpage>&#x02013;<lpage>1551</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201040425</pub-id><?supplied-pmid 20333626?><pub-id pub-id-type="pmid">20333626</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klevens</surname><given-names>R. M.</given-names></name><name><surname>Morrison</surname><given-names>M. A.</given-names></name><name><surname>Nadle</surname><given-names>J.</given-names></name><name><surname>Petit</surname><given-names>S.</given-names></name><name><surname>Gershman</surname><given-names>K.</given-names></name><name><surname>Ray</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Invasive methicillin-resistant <italic>Staphylococcus aureus</italic> infections in the United States</article-title>. <source>Jama</source>
<volume>298</volume>, <fpage>1763</fpage>&#x02013;<lpage>1771</lpage>
<pub-id pub-id-type="doi">10.1001/jama.298.15.1763</pub-id><?supplied-pmid 17940231?><pub-id pub-id-type="pmid">17940231</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofoed</surname><given-names>E. M.</given-names></name><name><surname>Vance</surname><given-names>R. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity</article-title>. <source>Nature</source>
<volume>477</volume>, <fpage>592</fpage>&#x02013;<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1038/nature10394</pub-id><?supplied-pmid 21874021?><pub-id pub-id-type="pmid">21874021</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotredes</surname><given-names>K. P.</given-names></name><name><surname>Gamero</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Interferons as inducers of apoptosis in malignant cells</article-title>. <source>J. Interferon Cytokine Res</source>. <volume>33</volume>, <fpage>162</fpage>&#x02013;<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1089/jir.2012.0110</pub-id><?supplied-pmid 23570382?><pub-id pub-id-type="pmid">23570382</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liljeroos</surname><given-names>M.</given-names></name><name><surname>Vuolteenaho</surname><given-names>R.</given-names></name><name><surname>Rounioja</surname><given-names>S.</given-names></name><name><surname>Henriques-Normark</surname><given-names>B.</given-names></name><name><surname>Hallman</surname><given-names>M.</given-names></name><name><surname>Ojaniemi</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-alpha production</article-title>. <source>Cell Signal</source>
<volume>20</volume>, <fpage>1873</fpage>&#x02013;<lpage>1881</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2008.06.017</pub-id><?supplied-pmid 18652890?><pub-id pub-id-type="pmid">18652890</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindgren</surname><given-names>S. W.</given-names></name><name><surname>Stojiljkovic</surname><given-names>I.</given-names></name><name><surname>Heffron</surname><given-names>F.</given-names></name></person-group> (<year>1996</year>). <article-title>Macrophage killing is an essential virulence mechanism of <italic>Salmonella typhimurium</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>93</volume>, <fpage>4197</fpage>&#x02013;<lpage>4201</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.9.4197</pub-id><?supplied-pmid 8633040?><pub-id pub-id-type="pmid">8633040</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>J.</given-names></name><name><surname>Muller</surname><given-names>H. C.</given-names></name><name><surname>Naujoks</surname><given-names>J.</given-names></name><name><surname>Tabeling</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>S.</given-names></name><name><surname>Witzenrath</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice</article-title>. <source>Cell Microbiol</source>. <volume>13</volume>, <fpage>1668</fpage>&#x02013;<lpage>1682</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2011.01646.x</pub-id><?supplied-pmid 21790939?><pub-id pub-id-type="pmid">21790939</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. J.</given-names></name></person-group> (<year>2005</year>). <article-title>IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors</article-title>. <source>Annu. Rev. Immunol</source>. <volume>23</volume>, <fpage>275</fpage>&#x02013;<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115633</pub-id><?supplied-pmid 15771572?><pub-id pub-id-type="pmid">15771572</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizak</surname><given-names>M.</given-names></name><name><surname>Yarovinsky</surname><given-names>T. O.</given-names></name></person-group> (<year>2012</year>). <article-title>Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal alpha-toxin</article-title>. <source>Cell Host Microbe</source>
<volume>11</volume>, <fpage>70</fpage>&#x02013;<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2011.12.004</pub-id><?supplied-pmid 22264514?><pub-id pub-id-type="pmid">22264514</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupfer</surname><given-names>C. R.</given-names></name><name><surname>Kanneganti</surname><given-names>T. D.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of inflammasome modulation in virulence</article-title>. <source>Virulence</source>
<volume>3</volume>, <fpage>262</fpage>&#x02013;<lpage>270</lpage>
<pub-id pub-id-type="doi">10.4161/viru.20266</pub-id><?supplied-pmid 22546900?><pub-id pub-id-type="pmid">22546900</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Interferon-inducible effector mechanisms in cell-autonomous immunity</article-title>. <source>Nat. Rev. Immunol</source>. <volume>12</volume>, <fpage>367</fpage>&#x02013;<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1038/nri3210</pub-id><?supplied-pmid 22531325?><pub-id pub-id-type="pmid">22531325</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majer</surname><given-names>O.</given-names></name><name><surname>Bourgeois</surname><given-names>C.</given-names></name><name><surname>Zwolanek</surname><given-names>F.</given-names></name><name><surname>Lassnig</surname><given-names>C.</given-names></name><name><surname>Kerjaschki</surname><given-names>D.</given-names></name><name><surname>Mack</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections</article-title>. <source>PLoS Pathog</source>. <volume>8</volume>:<fpage>e1002811</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1002811</pub-id><?supplied-pmid 22911155?><pub-id pub-id-type="pmid">22911155</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Bergtold</surname><given-names>A.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Musser</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>98</volume>, <fpage>5752</fpage>&#x02013;<lpage>5757</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><?supplied-pmid 11320211?><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name><name><surname>Vucic</surname><given-names>D.</given-names></name><name><surname>French</surname><given-names>D. M.</given-names></name><name><surname>Lee</surname><given-names>W. P.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf</article-title>. <source>Nature</source>
<volume>430</volume>, <fpage>213</fpage>&#x02013;<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1038/nature02664</pub-id><?supplied-pmid 15190255?><pub-id pub-id-type="pmid">15190255</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S.</given-names></name><name><surname>Weiss</surname><given-names>D. S.</given-names></name><name><surname>Dixit</surname><given-names>V. M.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Innate immunity against <italic>Francisella tularensis</italic> is dependent on the ASC/caspase-1 axis</article-title>. <source>J. Exp. Med</source>. <volume>202</volume>, <fpage>1043</fpage>&#x02013;<lpage>1049</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20050977</pub-id><?supplied-pmid 16230474?><pub-id pub-id-type="pmid">16230474</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S.</given-names></name><name><surname>Weiss</surname><given-names>D. S.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>McBride</surname><given-names>J.</given-names></name><name><surname>O'Rourke</surname><given-names>K.</given-names></name><name><surname>Roose-Girma</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Cryopyrin activates the inflammasome in response to toxins and ATP</article-title>. <source>Nature</source>
<volume>440</volume>, <fpage>228</fpage>&#x02013;<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1038/nature04515</pub-id><?supplied-pmid 16407890?><pub-id pub-id-type="pmid">16407890</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>F. J.</given-names></name><name><surname>Gomez</surname><given-names>M. I.</given-names></name><name><surname>Wetzel</surname><given-names>D. M.</given-names></name><name><surname>Memmi</surname><given-names>G.</given-names></name><name><surname>O'Seaghdha</surname><given-names>M.</given-names></name><name><surname>Soong</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title><italic>Staphylococcus aureus</italic> activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A</article-title>. <source>J. Clin. Invest</source>. <volume>119</volume>, <fpage>1931</fpage>&#x02013;<lpage>1939</lpage>
<pub-id pub-id-type="doi">10.1172/JCI35879</pub-id><?supplied-pmid 19603548?><pub-id pub-id-type="pmid">19603548</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>S. L.</given-names></name><name><surname>Gerlic</surname><given-names>M.</given-names></name><name><surname>Metcalf</surname><given-names>D.</given-names></name><name><surname>Preston</surname><given-names>S.</given-names></name><name><surname>Pellegrini</surname><given-names>M.</given-names></name><name><surname>O'Donnell</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells</article-title>. <source>Immunity</source>
<volume>37</volume>, <fpage>1009</fpage>&#x02013;<lpage>1023</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2012.08.027</pub-id><?supplied-pmid 23219391?><pub-id pub-id-type="pmid">23219391</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Andrade</surname><given-names>B. B.</given-names></name><name><surname>Barber</surname><given-names>D. L.</given-names></name><name><surname>Hieny</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source>
<volume>35</volume>, <fpage>1023</fpage>&#x02013;<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id><?supplied-pmid 22195750?><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>E. A.</given-names></name><name><surname>Alpuche-Aranda</surname><given-names>C. M.</given-names></name><name><surname>Dors</surname><given-names>M.</given-names></name><name><surname>Clark</surname><given-names>A. E.</given-names></name><name><surname>Bader</surname><given-names>M. W.</given-names></name><name><surname>Miller</surname><given-names>S. I.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf</article-title>. <source>Nat. Immunol</source>. <volume>7</volume>, <fpage>569</fpage>&#x02013;<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1038/ni1344</pub-id><?supplied-pmid 16648853?><pub-id pub-id-type="pmid">16648853</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>E. A.</given-names></name><name><surname>Ernst</surname><given-names>R. K.</given-names></name><name><surname>Dors</surname><given-names>M.</given-names></name><name><surname>Mao</surname><given-names>D. P.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Pseudomonas aeruginosa</italic> activates caspase 1 through Ipaf</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>2562</fpage>&#x02013;<lpage>2567</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0712183105</pub-id><?supplied-pmid 18256184?><pub-id pub-id-type="pmid">18256184</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moayeri</surname><given-names>M.</given-names></name><name><surname>Crown</surname><given-names>D.</given-names></name><name><surname>Newman</surname><given-names>Z. L.</given-names></name><name><surname>Okugawa</surname><given-names>S.</given-names></name><name><surname>Eckhaus</surname><given-names>M.</given-names></name><name><surname>Cataisson</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment</article-title>. <source>PLoS Pathog</source>. <volume>6</volume>:<fpage>e1001222</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1001222</pub-id><?supplied-pmid 21170303?><pub-id pub-id-type="pmid">21170303</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>K. M.</given-names></name><name><surname>McWhirter</surname><given-names>S. M.</given-names></name><name><surname>Vance</surname><given-names>R. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to <italic>Legionella pneumophila</italic></article-title>. <source>PLoS Pathog</source>. <volume>5</volume>:<fpage>e1000665</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000665</pub-id><?supplied-pmid 19936053?><pub-id pub-id-type="pmid">19936053</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>D. M.</given-names></name><name><surname>Taubenberger</surname><given-names>J. K.</given-names></name><name><surname>Fauci</surname><given-names>A. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness</article-title>. <source>J. Infect. Dis</source>. <volume>198</volume>, <fpage>962</fpage>&#x02013;<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1086/591708</pub-id><?supplied-pmid 18710327?><pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>M. G.</given-names></name><name><surname>Brown</surname><given-names>G. D.</given-names></name><name><surname>Kullberg</surname><given-names>B. J.</given-names></name><name><surname>Gow</surname><given-names>N. A.</given-names></name></person-group> (<year>2008</year>). <article-title>An integrated model of the recognition of <italic>Candida albicans</italic> by the innate immune system</article-title>. <source>Nat. Rev. Microbiol</source>. <volume>6</volume>, <fpage>67</fpage>&#x02013;<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro1815</pub-id><?supplied-pmid 18079743?><pub-id pub-id-type="pmid">18079743</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>C. V.</given-names></name><name><surname>Lindsten</surname><given-names>T.</given-names></name><name><surname>Jamieson</surname><given-names>A. M.</given-names></name><name><surname>Case</surname><given-names>C. L.</given-names></name><name><surname>Shin</surname><given-names>S.</given-names></name><name><surname>Thompson</surname><given-names>C. B.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of <italic>Legionella pneumophila</italic></article-title>. <source>PLoS Pathog</source>. <volume>5</volume>:<fpage>e1000478</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000478</pub-id><?supplied-pmid 19521510?><pub-id pub-id-type="pmid">19521510</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A.</given-names></name><name><surname>Cardone</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>Kirschman</surname><given-names>K. D.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title>. <source>J. Immunol</source>. <volume>187</volume>, <fpage>2540</fpage>&#x02013;<lpage>2547</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1100926</pub-id><?supplied-pmid 21784976?><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connell</surname><given-names>R. M.</given-names></name><name><surname>Saha</surname><given-names>S. K.</given-names></name><name><surname>Vaidya</surname><given-names>S. A.</given-names></name><name><surname>Bruhn</surname><given-names>K. W.</given-names></name><name><surname>Miranda</surname><given-names>G. A.</given-names></name><name><surname>Zarnegar</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Type I interferon production enhances susceptibility to <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J. Exp. Med</source>. <volume>200</volume>, <fpage>437</fpage>&#x02013;<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20040712</pub-id><?supplied-pmid 15302901?><pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opitz</surname><given-names>B.</given-names></name><name><surname>Vinzing</surname><given-names>M.</given-names></name><name><surname>van Laak</surname><given-names>V.</given-names></name><name><surname>Schmeck</surname><given-names>B.</given-names></name><name><surname>Heine</surname><given-names>G.</given-names></name><name><surname>Gunther</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2006</year>). <italic>Legionella pneumophila</italic> induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. <italic>J. Biol. Chem.</italic>
<volume>281</volume>, <fpage>36173</fpage>&#x02013;<lpage>36179</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M604638200</pub-id><?supplied-pmid 16984921?><pub-id pub-id-type="pmid">16984921</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Riordan</surname><given-names>M.</given-names></name><name><surname>Yi</surname><given-names>C. H.</given-names></name><name><surname>Gonzales</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>K. D.</given-names></name><name><surname>Portnoy</surname><given-names>D. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Innate recognition of bacteria by a macrophage cytosolic surveillance pathway</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>99</volume>, <fpage>13861</fpage>&#x02013;<lpage>13866</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.202476699</pub-id><?supplied-pmid 12359878?><pub-id pub-id-type="pmid">12359878</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmero</surname><given-names>D.</given-names></name><name><surname>Eiguchi</surname><given-names>K.</given-names></name><name><surname>Rendo</surname><given-names>P.</given-names></name><name><surname>Castro Zorrilla</surname><given-names>L.</given-names></name><name><surname>Abbate</surname><given-names>E.</given-names></name><name><surname>Gonzalez Montaner</surname><given-names>L. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up</article-title>. <source>Int. J. Tuberc. Lung Dis</source>. <volume>3</volume>, <fpage>214</fpage>&#x02013;<lpage>218</lpage>
<?supplied-pmid 10094322?><pub-id pub-id-type="pmid">10094322</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pamer</surname><given-names>E. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Immune responses to <italic>Listeria monocytogenes</italic></article-title>. <source>Nat. Rev. Immunol</source>. <volume>4</volume>, <fpage>812</fpage>&#x02013;<lpage>823</lpage>
<pub-id pub-id-type="doi">10.1038/nri1461</pub-id><?supplied-pmid 15459672?><pub-id pub-id-type="pmid">15459672</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A. K.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Fortune</surname><given-names>S. M.</given-names></name><name><surname>Coulombe</surname><given-names>F.</given-names></name><name><surname>Behr</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source>. <volume>5</volume>:<fpage>e1000500</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id><?supplied-pmid 19578435?><pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D.</given-names></name><name><surname>Cohen</surname><given-names>T. S.</given-names></name><name><surname>Alhede</surname><given-names>M.</given-names></name><name><surname>Harfenist</surname><given-names>B. S.</given-names></name><name><surname>Martin</surname><given-names>F. J.</given-names></name><name><surname>Prince</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Induction of type I interferon signaling by <italic>Pseudomonas aeruginosa</italic> is diminished in cystic fibrosis epithelial cells</article-title>. <source>Am. J. Respir. Cell Mol. Biol</source>. <volume>46</volume>, <fpage>6</fpage>&#x02013;<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2011-0080OC</pub-id><?supplied-pmid 21778412?><pub-id pub-id-type="pmid">21778412</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D.</given-names></name><name><surname>Martin</surname><given-names>F. J.</given-names></name><name><surname>Soong</surname><given-names>G.</given-names></name><name><surname>Harfenist</surname><given-names>B. S.</given-names></name><name><surname>Aguilar</surname><given-names>J. L.</given-names></name><name><surname>Ratner</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title><italic>Streptococcus pneumoniae</italic> DNA initiates type I interferon signaling in the respiratory tract</article-title>. <source>MBio</source>
<volume>2</volume>, <fpage>e00016</fpage>&#x02013;<lpage>e00011</lpage>
<pub-id pub-id-type="doi">10.1128/mBio.00016-11</pub-id><?supplied-pmid 21586648?><pub-id pub-id-type="pmid">21586648</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>S.</given-names></name><name><surname>Krause</surname><given-names>C. D.</given-names></name><name><surname>Walter</surname><given-names>M. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Interferons, interferon-like cytokines, and their receptors</article-title>. <source>Immunol. Rev</source>. <volume>202</volume>, <fpage>8</fpage>&#x02013;<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00204.x</pub-id><?supplied-pmid 15546383?><pub-id pub-id-type="pmid">15546383</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname><given-names>L. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title>. <source>Nat. Rev. Immunol</source>. <volume>5</volume>, <fpage>375</fpage>&#x02013;<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1038/nri1604</pub-id><?supplied-pmid 15864272?><pub-id pub-id-type="pmid">15864272</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poeck</surname><given-names>H.</given-names></name><name><surname>Bscheider</surname><given-names>M.</given-names></name><name><surname>Gross</surname><given-names>O.</given-names></name><name><surname>Finger</surname><given-names>K.</given-names></name><name><surname>Roth</surname><given-names>S.</given-names></name><name><surname>Rebsamen</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production</article-title>. <source>Nat. Immunol</source>. <volume>11</volume>, <fpage>63</fpage>&#x02013;<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1824</pub-id><?supplied-pmid 19915568?><pub-id pub-id-type="pmid">19915568</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portnoy</surname><given-names>D. A.</given-names></name><name><surname>Jacks</surname><given-names>P. S.</given-names></name><name><surname>Hinrichs</surname><given-names>D. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Role of hemolysin for the intracellular growth of <italic>Listeria monocytogenes</italic></article-title>. <source>J. Exp. Med</source>. <volume>167</volume>, <fpage>1459</fpage>&#x02013;<lpage>1471</lpage>
<pub-id pub-id-type="doi">10.1084/jem.167.4.1459</pub-id><?supplied-pmid 2833557?><pub-id pub-id-type="pmid">2833557</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pothlichet</surname><given-names>J.</given-names></name><name><surname>Meunier</surname><given-names>I.</given-names></name><name><surname>Davis</surname><given-names>B. K.</given-names></name><name><surname>Ting</surname><given-names>J. P.</given-names></name><name><surname>Skamene</surname><given-names>E.</given-names></name><name><surname>von Messling</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells</article-title>. <source>PLoS Pathog</source>. <volume>9</volume>:<fpage>e1003256</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003256</pub-id><?supplied-pmid 23592984?><pub-id pub-id-type="pmid">23592984</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>M. R.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>T. J.</given-names></name></person-group> (<year>2007</year>). <article-title>A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to <italic>Pseudomonas aeruginosa</italic> lung infection in mice</article-title>. <source>J. Immunol</source>. <volume>178</volume>, <fpage>3170</fpage>&#x02013;<lpage>3176</lpage>
<?supplied-pmid 17312165?><pub-id pub-id-type="pmid">17312165</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramphal</surname><given-names>R.</given-names></name><name><surname>Balloy</surname><given-names>V.</given-names></name><name><surname>Huerre</surname><given-names>M.</given-names></name><name><surname>Si-Tahar</surname><given-names>M.</given-names></name><name><surname>Chignard</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>TLRs 2 and 4 are not involved in hypersusceptibility to acute <italic>Pseudomonas aeruginosa</italic> lung infections</article-title>. <source>J. Immunol</source>. <volume>175</volume>, <fpage>3927</fpage>&#x02013;<lpage>3934</lpage>
<?supplied-pmid 16272281?><pub-id pub-id-type="pmid">16148139</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>V. A.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Waggoner</surname><given-names>S. N.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Cole</surname><given-names>L. E.</given-names></name><name><surname>Waggoner</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses</article-title>. <source>Nat. Immunol</source>. <volume>11</volume>, <fpage>395</fpage>&#x02013;<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1864</pub-id><?supplied-pmid 20351692?><pub-id pub-id-type="pmid">20351692</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>V. A.</given-names></name><name><surname>Vanaja</surname><given-names>S. K.</given-names></name><name><surname>Waggoner</surname><given-names>L.</given-names></name><name><surname>Sokolovska</surname><given-names>A.</given-names></name><name><surname>Becker</surname><given-names>C.</given-names></name><name><surname>Stuart</surname><given-names>L. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria</article-title>. <source>Cell</source>
<volume>150</volume>, <fpage>606</fpage>&#x02013;<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.07.007</pub-id><?supplied-pmid 22819539?><pub-id pub-id-type="pmid">22819539</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M.</given-names></name><name><surname>Humann</surname><given-names>J.</given-names></name><name><surname>Penheiter</surname><given-names>K.</given-names></name><name><surname>Andreasen</surname><given-names>K.</given-names></name><name><surname>Lenz</surname><given-names>L. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Induction of IFN-alphabeta enables <italic>Listeria monocytogenes</italic> to suppress macrophage activation by IFN-gamma</article-title>. <source>J. Exp. Med</source>. <volume>207</volume>, <fpage>327</fpage>&#x02013;<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20091746</pub-id><?supplied-pmid 20123961?><pub-id pub-id-type="pmid">20123961</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>N. C.</given-names></name></person-group> (<year>2013</year>). <article-title>A death-promoting role for ISG54/IFIT2</article-title>. <source>J. Interferon Cytokine Res</source>. <volume>33</volume>, <fpage>199</fpage>&#x02013;<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1089/jir.2012.0159</pub-id><?supplied-pmid 23570386?><pub-id pub-id-type="pmid">23570386</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>T.</given-names></name><name><surname>Schweizer</surname><given-names>M.</given-names></name><name><surname>Jungi</surname><given-names>T. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Type I IFN induction in response to <italic>Listeria monocytogenes</italic> in human macrophages: evidence for a differential activation of IFN regulatory factor 3 (IRF3)</article-title>. <source>J. Immunol</source>. <volume>179</volume>, <fpage>1166</fpage>&#x02013;<lpage>1177</lpage>
<?supplied-pmid 17617610?><pub-id pub-id-type="pmid">17617610</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>N.</given-names></name><name><surname>McComb</surname><given-names>S.</given-names></name><name><surname>Mulligan</surname><given-names>R.</given-names></name><name><surname>Dudani</surname><given-names>R.</given-names></name><name><surname>Krishnan</surname><given-names>L.</given-names></name><name><surname>Sad</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Type I interferon induces necroptosis in macrophages during infection with <italic>Salmonella enterica</italic> serovar Typhimurium</article-title>. <source>Nat. Immunol</source>. <volume>13</volume>, <fpage>954</fpage>&#x02013;<lpage>962</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2397</pub-id><?supplied-pmid 22922364?><pub-id pub-id-type="pmid">22922364</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roquilly</surname><given-names>A.</given-names></name><name><surname>Gautreau</surname><given-names>L.</given-names></name><name><surname>Segain</surname><given-names>J. P.</given-names></name><name><surname>de Coppet</surname><given-names>P.</given-names></name><name><surname>Sebille</surname><given-names>V.</given-names></name><name><surname>Jacqueline</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-<italic>Staphyloccocus aureus</italic> pneumonia</article-title>. <source>PLoS ONE</source>
<volume>5</volume>:<fpage>e13228</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0013228</pub-id><?supplied-pmid 20949109?><pub-id pub-id-type="pmid">20949109</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Bonfield</surname><given-names>T.</given-names></name><name><surname>Tartakoff</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Non-apoptotic toxicity of <italic>Pseudomonas aeruginosa</italic> toward murine cells</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e54245</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0054245</pub-id><?supplied-pmid 23358229?><pub-id pub-id-type="pmid">23358229</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusinova</surname><given-names>I.</given-names></name><name><surname>Forster</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Kannan</surname><given-names>A.</given-names></name><name><surname>Masse</surname><given-names>M.</given-names></name><name><surname>Cumming</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Interferome v2.0: an updated database of annotated interferon-regulated genes</article-title>. <source>Nucleic Acids Res</source>. <volume>41</volume>, <fpage>D1040</fpage>&#x02013;<lpage>D1046</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks1215</pub-id><?supplied-pmid 23203888?><pub-id pub-id-type="pmid">23203888</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>L. E.</given-names></name><name><surname>Davis</surname><given-names>M. J.</given-names></name><name><surname>Boekschoten</surname><given-names>M. V.</given-names></name><name><surname>Amsen</surname><given-names>D.</given-names></name><name><surname>Dascher</surname><given-names>C. C.</given-names></name><name><surname>Ryffel</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Detection of prokaryotic mRNA signifies microbial viability and promotes immunity</article-title>. <source>Nature</source>
<volume>474</volume>, <fpage>385</fpage>&#x02013;<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1038/nature10072</pub-id><?supplied-pmid 21602824?><pub-id pub-id-type="pmid">21602824</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Sugiyama</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>Y.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling</article-title>. <source>J. Immunol</source>. <volume>171</volume>, <fpage>4304</fpage>&#x02013;<lpage>4310</lpage>
<?supplied-pmid 14530355?><pub-id pub-id-type="pmid">14530355</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>J. D.</given-names></name><name><surname>Witte</surname><given-names>C. E.</given-names></name><name><surname>Zemansky</surname><given-names>J.</given-names></name><name><surname>Hanson</surname><given-names>B.</given-names></name><name><surname>Lauer</surname><given-names>P.</given-names></name><name><surname>Portnoy</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Listeria monocytogenes</italic> triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol</article-title>. <source>Cell Host Microbe</source>
<volume>7</volume>, <fpage>412</fpage>&#x02013;<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2010.04.004</pub-id><?supplied-pmid 20417169?><pub-id pub-id-type="pmid">20417169</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavoni</surname><given-names>G.</given-names></name><name><surname>Mauri</surname><given-names>C.</given-names></name><name><surname>Carlei</surname><given-names>D.</given-names></name><name><surname>Belardelli</surname><given-names>F.</given-names></name><name><surname>Pastoris</surname><given-names>M. C.</given-names></name><name><surname>Proietti</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Type I IFN protects permissive macrophages from <italic>Legionella pneumophila</italic> infection through an IFN-gamma-independent pathway</article-title>. <source>J. Immunol</source>. <volume>173</volume>, <fpage>1266</fpage>&#x02013;<lpage>1275</lpage>
<?supplied-pmid 15240719?><pub-id pub-id-type="pmid">15240719</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>F.</given-names></name><name><surname>Heit</surname><given-names>A.</given-names></name><name><surname>Guggemoos</surname><given-names>S.</given-names></name><name><surname>Krug</surname><given-names>A.</given-names></name><name><surname>Mages</surname><given-names>J.</given-names></name><name><surname>Schiemann</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells</article-title>. <source>Eur. J. Immunol</source>. <volume>37</volume>, <fpage>315</fpage>&#x02013;<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1002/eji.200636767</pub-id><?supplied-pmid 17273999?><pub-id pub-id-type="pmid">17273999</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A.</given-names></name><name><surname>Chow</surname><given-names>E. K.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Kang</surname><given-names>J. R.</given-names></name><name><surname>Ghaffari</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source>J. Clin. Invest</source>. <volume>119</volume>, <fpage>1910</fpage>&#x02013;<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1172/JCI35412</pub-id><?supplied-pmid 19487810?><pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skerrett</surname><given-names>S. J.</given-names></name><name><surname>Wilson</surname><given-names>C. B.</given-names></name><name><surname>Liggitt</surname><given-names>H. D.</given-names></name><name><surname>Hajjar</surname><given-names>A. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Redundant Toll-like receptor signaling in the pulmonary host response to <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol</source>. <volume>292</volume>, <fpage>L312</fpage>&#x02013;<lpage>L322</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00250.2006</pub-id><?supplied-pmid 16936244?><pub-id pub-id-type="pmid">16936244</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>D. B.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group> (<year>2006a</year>). <article-title>Recognition of cytosolic DNA activates an IRF3-dependent innate immune response</article-title>. <source>Immunity</source>
<volume>24</volume>, <fpage>93</fpage>&#x02013;<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2005.12.003</pub-id><?supplied-pmid 16413926?><pub-id pub-id-type="pmid">16413926</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>D. B.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group> (<year>2006b</year>). <article-title>Type I interferons in host defense</article-title>. <source>Immunity</source>
<volume>25</volume>, <fpage>373</fpage>&#x02013;<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.007</pub-id><?supplied-pmid 16979569?><pub-id pub-id-type="pmid">16979569</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutterwala</surname><given-names>F. S.</given-names></name><name><surname>Mijares</surname><given-names>L. A.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Ogura</surname><given-names>Y.</given-names></name><name><surname>Kazmierczak</surname><given-names>B. I.</given-names></name><name><surname>Flavell</surname><given-names>R. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Immune recognition of <italic>Pseudomonas aeruginosa</italic> mediated by the IPAF/NLRC4 inflammasome</article-title>. <source>J. Exp. Med</source>. <volume>204</volume>, <fpage>3235</fpage>&#x02013;<lpage>3245</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20071239</pub-id><?supplied-pmid 18070936?><pub-id pub-id-type="pmid">18070936</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutterwala</surname><given-names>F. S.</given-names></name><name><surname>Ogura</surname><given-names>Y.</given-names></name><name><surname>Szczepanik</surname><given-names>M.</given-names></name><name><surname>Lara-Tejero</surname><given-names>M.</given-names></name><name><surname>Lichtenberger</surname><given-names>G. S.</given-names></name><name><surname>Grant</surname><given-names>E. P.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1</article-title>. <source>Immunity</source>
<volume>24</volume>, <fpage>317</fpage>&#x02013;<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2006.02.004</pub-id><?supplied-pmid 16546100?><pub-id pub-id-type="pmid">16546100</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiecki</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Vermi</surname><given-names>W.</given-names></name><name><surname>Gilfillan</surname><given-names>S.</given-names></name><name><surname>Schreiber</surname><given-names>R. D.</given-names></name><name><surname>Colonna</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Type I interferon negatively controls plasmacytoid dendritic cell numbers <italic>in vivo</italic></article-title>. <source>J. Exp. Med</source>. <volume>208</volume>, <fpage>2367</fpage>&#x02013;<lpage>2374</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20110654</pub-id><?supplied-pmid 22084408?><pub-id pub-id-type="pmid">22084408</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source>
<volume>140</volume>, <fpage>805</fpage>&#x02013;<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><?supplied-pmid 20303872?><pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>J. R.</given-names></name><name><surname>Ng</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>A. M.</given-names></name><name><surname>Sullivan</surname><given-names>B. M.</given-names></name><name><surname>Sheehan</surname><given-names>K. C.</given-names></name><name><surname>Welch</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Persistent LCMV infection is controlled by blockade of type I interferon signaling</article-title>. <source>Science</source>
<volume>340</volume>, <fpage>207</fpage>&#x02013;<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1126/science.1235214</pub-id><?supplied-pmid 23580529?><pub-id pub-id-type="pmid">23580529</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>R. M.</given-names></name><name><surname>Graeber</surname><given-names>T. G.</given-names></name><name><surname>Krutzik</surname><given-names>S. R.</given-names></name><name><surname>Montoya</surname><given-names>D.</given-names></name><name><surname>Schenk</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source>
<volume>339</volume>, <fpage>1448</fpage>&#x02013;<lpage>1453</lpage>
<pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><?supplied-pmid 23449998?><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terra</surname><given-names>J. K.</given-names></name><name><surname>Cote</surname><given-names>C. K.</given-names></name><name><surname>France</surname><given-names>B.</given-names></name><name><surname>Jenkins</surname><given-names>A. L.</given-names></name><name><surname>Bozue</surname><given-names>J. A.</given-names></name><name><surname>Welkos</surname><given-names>S. L.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Cutting edge: resistance to <italic>Bacillus anthracis</italic> infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b</article-title>. <source>J. Immunol</source>. <volume>184</volume>, <fpage>17</fpage>&#x02013;<lpage>20</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903114</pub-id><?supplied-pmid 19949100?><pub-id pub-id-type="pmid">19949100</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>P. G.</given-names></name><name><surname>Dash</surname><given-names>P.</given-names></name><name><surname>Aldridge</surname><given-names>J. R.</given-names><suffix>Jr.</suffix></name><name><surname>Ellebedy</surname><given-names>A. H.</given-names></name><name><surname>Reynolds</surname><given-names>C.</given-names></name><name><surname>Funk</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1</article-title>. <source>Immunity</source>
<volume>30</volume>, <fpage>566</fpage>&#x02013;<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.006</pub-id><?supplied-pmid 19362023?><pub-id pub-id-type="pmid">19362023</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>H.</given-names></name><name><surname>Kawamura</surname><given-names>I.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Daim</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with <italic>Listeria monocytogenes</italic></article-title>. <source>J. Immunol</source>. <volume>185</volume>, <fpage>1186</fpage>&#x02013;<lpage>1195</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1001058</pub-id><?supplied-pmid 20566831?><pub-id pub-id-type="pmid">20566831</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vladimer</surname><given-names>G. I.</given-names></name><name><surname>Weng</surname><given-names>D.</given-names></name><name><surname>Paquette</surname><given-names>S. W.</given-names></name><name><surname>Vanaja</surname><given-names>S. K.</given-names></name><name><surname>Rathinam</surname><given-names>V. A.</given-names></name><name><surname>Aune</surname><given-names>M. H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The NLRP12 inflammasome recognizes <italic>Yersinia pestis</italic></article-title>. <source>Immunity</source>
<volume>37</volume>, <fpage>96</fpage>&#x02013;<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2012.07.006</pub-id><?supplied-pmid 22840842?><pub-id pub-id-type="pmid">22840842</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walberg</surname><given-names>K.</given-names></name><name><surname>Baron</surname><given-names>S.</given-names></name><name><surname>Poast</surname><given-names>J.</given-names></name><name><surname>Schwartz</surname><given-names>B.</given-names></name><name><surname>Izotova</surname><given-names>L.</given-names></name><name><surname>Pestka</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Interferon protects mice against inhalation anthrax</article-title>. <source>J. Interferon Cytokine Res</source>. <volume>28</volume>, <fpage>597</fpage>&#x02013;<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1089/jir.2007.0143</pub-id><?supplied-pmid 18778201?><pub-id pub-id-type="pmid">18778201</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Miura</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>Y. K.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE</article-title>. <source>Cell</source>
<volume>92</volume>, <fpage>501</fpage>&#x02013;<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80943-5</pub-id><?supplied-pmid 9491891?><pub-id pub-id-type="pmid">9491891</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>S. E.</given-names></name><name><surname>Mao</surname><given-names>D. P.</given-names></name><name><surname>Rodriguez</surname><given-names>A. E.</given-names></name><name><surname>Miao</surname><given-names>E. A.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Multiple Nod-like receptors activate caspase 1 during <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J. Immunol</source>. <volume>180</volume>, <fpage>7558</fpage>&#x02013;<lpage>7564</lpage>
<?supplied-pmid 18490757?><pub-id pub-id-type="pmid">18490757</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigent</surname><given-names>D. A.</given-names></name><name><surname>Huff</surname><given-names>T. L.</given-names></name><name><surname>Peterson</surname><given-names>J. W.</given-names></name><name><surname>Stanton</surname><given-names>G. J.</given-names></name><name><surname>Baron</surname><given-names>S.</given-names></name></person-group> (<year>1986</year>). <article-title>Role of interferon in streptococcal infection in the mouse</article-title>. <source>Microb. Pathog</source>. <volume>1</volume>, <fpage>399</fpage>&#x02013;<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1016/0882-4010(86)90071-9</pub-id><?supplied-pmid 2469934?><pub-id pub-id-type="pmid">2469934</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>E. B.</given-names></name><name><surname>Yamada</surname><given-names>D. H.</given-names></name><name><surname>Elsaesser</surname><given-names>H.</given-names></name><name><surname>Herskovitz</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title>. <source>Science</source>
<volume>340</volume>, <fpage>202</fpage>&#x02013;<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1126/science.1235208</pub-id><?supplied-pmid 23580528?><pub-id pub-id-type="pmid">23580528</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>J. J.</given-names></name><name><surname>Iavarone</surname><given-names>A. T.</given-names></name><name><surname>Portnoy</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>c-di-AMP secreted by intracellular <italic>Listeria monocytogenes</italic> activates a host type I interferon response</article-title>. <source>Science</source>
<volume>328</volume>, <fpage>1703</fpage>&#x02013;<lpage>1705</lpage>
<pub-id pub-id-type="doi">10.1126/science.1189801</pub-id><?supplied-pmid 20508090?><pub-id pub-id-type="pmid">20508090</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worthington</surname><given-names>M.</given-names></name><name><surname>Hasenclever</surname><given-names>H.</given-names></name></person-group> (<year>1972</year>). <article-title>Effect of an interferon stimulator, polyinosinic: polycytidylic acid, on experimental fungus infections</article-title>. <source>Infect. Immun</source>. <volume>5</volume>, <fpage>199</fpage>&#x02013;<lpage>202</lpage>
<?supplied-pmid 4564399?><pub-id pub-id-type="pmid">4564399</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Fernandes-Alnemri</surname><given-names>T.</given-names></name><name><surname>Alnemri</surname><given-names>E. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by <italic>Listeria monocytogenes</italic></article-title>. <source>J. Clin. Immunol</source>. <volume>30</volume>, <fpage>693</fpage>&#x02013;<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1007/s10875-010-9425-2</pub-id><?supplied-pmid 20490635?><pub-id pub-id-type="pmid">20490635</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>D.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Levillain</surname><given-names>F.</given-names></name><name><surname>Jin</surname><given-names>W.</given-names></name><name><surname>Mei</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>An interferon-related signature in the transcriptional core response of human macrophages to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e38367</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0038367</pub-id><?supplied-pmid 22675550?><pub-id pub-id-type="pmid">22675550</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Hemmi</surname><given-names>H.</given-names></name><name><surname>Hoshino</surname><given-names>K.</given-names></name><name><surname>Kaisho</surname><given-names>T.</given-names></name><name><surname>Sanjo</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway</article-title>. <source>Science</source>
<volume>301</volume>, <fpage>640</fpage>&#x02013;<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1126/science.1087262</pub-id><?supplied-pmid 12855817?><pub-id pub-id-type="pmid">12855817</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>Y. N.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus</article-title>. <source>Nature</source>
<volume>477</volume>, <fpage>596</fpage>&#x02013;<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1038/nature10510</pub-id><?supplied-pmid 21918512?><pub-id pub-id-type="pmid">21918512</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuo</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Lynch</surname><given-names>S. V.</given-names></name><name><surname>Dotson</surname><given-names>R. H.</given-names></name><name><surname>Glidden</surname><given-names>D. V.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Increased mortality of ventilated patients with endotracheal <italic>Pseudomonas aeruginosa</italic> without clinical signs of infection</article-title>. <source>Crit. Care Med</source>. <volume>36</volume>, <fpage>2495</fpage>&#x02013;<lpage>2503</lpage>
<pub-id pub-id-type="doi">10.1097/CCM.0b013e318183f3f8</pub-id><?supplied-pmid 18679122?><pub-id pub-id-type="pmid">18679122</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>IFN-I</term><def><p>type I interferon</p></def></def-item><def-item><term>IFNAR</term><def><p>Interferon-&#x003b1;/&#x003b2; receptor</p></def></def-item><def-item><term>ISRE</term><def><p>Interferon stimulated response element</p></def></def-item><def-item><term>ISGs</term><def><p>Interferon stimulated genes</p></def></def-item><def-item><term>TLR</term><def><p>TOLL-like receptor</p></def></def-item><def-item><term>NLR</term><def><p>NOD-like receptor</p></def></def-item></def-list></glossary></back></article>